EurekaMag Full Text Articles Chapter 40,336

Quivey, M. 1988: ICN's relationship with WHO: a view from Europe. International Nursing Review 35(3): 67-68

Darley, M. 1985: ICN--a student's view of Tel Aviv. Nursing Mirror 161(4): 11

Vesterdal, A. 1989: ICN--nurses should belief in their own value. Sygeplejersken 89(44): 18-21

Demain, A.L. 1991: Production of beta-lactam antibiotics and its regulation. Proceedings of the National Science Council Republic of China. Part B Life Sciences 15(4): 251-265

Quinn, D.S. 1989: ICN--past and present. International Nursing Review 36(6): 174-175

Stallknecht, K.; Prasz, O. 1992: ICN--practical solidarity with Indian colleagues. Sygeplejersken 92(2): 26-27

Lysgaard, D. 1992: ICN--solidarity with colleagues in Ghana. Sygeplejersken 92(4): 21

Sourtze, P.A. 1991: ICN--taking care of the caretakers. Nurses: health and safety at work. Noseleutike 30(138): 252-265

Kim, S.J. 1989: ICN-CNR report. Taehan Kanho. Korean Nurse 28(3): 21-35

Monvall, E. 1977: ICN-Congresses, 1977. Vardfacket 1(16): 4-5

Stallknecht, K. 1989: ICN. Disproportion between need, competence and compensation. Sygeplejersken 89(33): 4-7; 31

Stallknecht, K. 1991: ICN. what does cooperation mean?. Sygeplejersken 91(49): 14-15

Vlassopoulos, G.; Sakkas, G.; Legaki, S.; Sofras, F.; Karagiannis, A. 1992: Inverted papilloma of the renal pelvis. International Urology and Nephrology 24(4): 345-346

Morgan, K.E. 1979: Why i say 'Yes' to joining the TUC. Nursing Mirror 149(17): 14

Anonymous 1990: ICN: African NNAs prepare for AIDS campaign. International Nursing Review 37(2): 224

Anonymous 1976: ICN; International Council of Nursing: code for nursing, ethical concepts applied to nursing. Boletin - Colegio de Profesionales de la Enfermeria de Puerto Rico 2(5): 12-13

Kadagidze, Z.G.; Tupitsyn, N.N.; Kadyrov, K.P.; Baryshnikov, A.I.; Mentkevich, G.L.; Matiakin, G.G.; Blinov, V.M. 1990: ICO-10 (Thy-1) and K-20 (gp 120/200) monoclonal antibodies in immunophenotyping of solid tumors in man. Voprosy Onkologii 36(3): 296-303

Korotkova, O.V.; Baryshnikov, A.I.; Tupitsyn, N.N.; Chimishkian, K.L.; Kostrykina, V.N. 1989: ICO-10 monoclonal antibodies to the Thy-1 antigen. Eksperimental'naia Onkologiia 11(2): 33-35

Korotkova, O.V.; Baryshnikov, A.I.; Tupitsyn, N.N.; Dubinkin, I.V.; Novikov, A.M. 1988: ICO-13 monoclonal antibodies to the differentiation antigen of human hemopoietic cells. Biulleten' Eksperimental'noi Biologii i Meditsiny 106(8): 207-209

Baryshnikov, A.I.; Tupitsyn, N.N.; Korotkova, O.V.; Kadagidze, Z.G.; Dostot, E.; Shmidt, M.; Boumsell, L. 1989: ICO-35 monoclonal antibodies to the antigen of acute lymphoblastic leukemia. Eksperimental'naia Onkologiia 11(5): 52-53

Baryshnikov, A.I.; Zabotina, T.N.; Dubinkin, I.V.; Korotkova, O.V.; Shchvartsbergs, A.M. 1989: ICO-45 monoclonal antibodies to the new epitope of antigen CD38. Biulleten' Eksperimental'noi Biologii i Meditsiny 107(6): 729-731

Baryshnikov, A.I.; Kadyrov, K.P.; Tupitsyn, N.N.; Kadagidze, Z.G.; Petrovichev, N.N. 1989: ICO-63 monoclonal antibodies to the differentiation antigen of hemopoietic cells suitable for immunophenotyping of human solid tumors. Eksperimental'naia Onkologiia 11(4): 41-44

Rotkovitch, R.; Smith, C. 1987: ICON I--the future model. ICON II--the transition model. Nursing Management 18(11): 91

Swett, H.A.; Miller, P.L. 1987: ICON: a computer-based approach to differential diagnosis in radiology. Radiology 163(2): 555-558

Rotkovitch, R. 1986: ICON: a model of nursing practice for the future. Nursing Management 17(6): 54-56

Tychmanowicz, K.; Czernicki, Z.; Pawłowski, G.; Stepińska, G. 1992: ICP dependent changes of CSF outflow resistance. Acta Neurochirurgica 117(1-2): 44-47

Marshall, L.F.; Eisenberg, H.M. 1987: ICP monitoring in severe head injury. Journal of Neurosurgery 67(6): 952-953

Miller, J.D. 1987: ICP monitoring--current status and future directions. Acta Neurochirurgica 85(3-4): 80-86

Rosner, M.J.; Becker, D.P. 1976: ICP monitoring: complications and associated factors. Clinical Neurosurgery 23: 494-519

Hayashi, M.; Kobayashi, H.; Kawano, H.; Handa, Y.; Yamamoto, S.; Kitano, T. 1985: ICP patterns and isotope cisternography in patients with communicating hydrocephalus following rupture of intracranial aneurysm. Journal of Neurosurgery 62(2): 220-226

Carteri, A.; Scanarini, M. 1986: ICP recording in non tumoral aqueductal stenosis. Journal of Neurosurgical Sciences 30(1-2): 17-18

Heifetz, M.D. 1987: ICP reduction with furosemide and mannitol. Journal of Neurosurgery 67(3): 475

Ferrer, E.; Vila, F.; Isamat, F. 1979: ICP response to mannitol in severe head injuries and other ICH pathologies: a histogram study. Acta Neurochirurgica. Suppl 28(2): 498

Emmett, S.E. 1989: ICP-MS: a new look at trace elements in Alzheimer's disease. Progress in Clinical and Biological Research 317: 1077-1086

Blaho, J.A.; Roizman, B. 1991: ICP4, the major regulatory protein of herpes simplex virus, shares features common to GTP-binding proteins and is adenylated and guanylated. Journal of Virology 65(7): 3759-3769

Tedder, D.G.; Everett, R.D.; Wilcox, K.W.; Beard, P.; Pizer, L.I. 1989: ICP4-binding sites in the promoter and coding regions of the herpes simplex virus gD gene contribute to activation of in vitro transcription by ICP4. Journal of Virology 63(6): 2510-2520

Brage, S.; Tellnes, G. 1992: ICPC in general practice. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 112(20): 2656-2659

Bridges, B.A. 1986: ICPEMC perspectives on the scientific basis of risk assessment in genetic toxicology. Progress in Clinical and Biological Research 208: 175-182

Grant, W.F. 1979: The genotoxic effects of 2,4,5-T. Mutation Research 65(2): 83-119

Anonymous 1978: ICPEMC to help protect against genetic diseases and cancer. Who Chronicle 32(10): 400-401

Spivack, G.; Shure, M.B. 1985: ICPS and beyond: centripetal and centrifugal forces. American Journal of Community Psychology 13(3): 226-243

Upton, E.L. 1988: ICPs and infection control guidelines. Infection Control and Hospital Epidemiology 9(2): 55

Deo, M.G. 1989: ICRC 'anti-leprosy vaccine'. Vaccine 7(2): 92-93

Ghaisas, S.; Saranath, D.; Deo, M.G. 1989: ICRC mouse with congenital mega-esophagus as a model to study esophageal tumorigenesis. Carcinogenesis 10(10): 1847-1854

Chirmule, N.B.; Deo, M.G.; Sirodkar, M.V.; Deshmukh, R.; Chanderkar, N.G. 1986: ICRC vaccine-induced changes in M. leprae-specific cell-mediated immunity in langur (Presbytis entellus) monkeys. International Journal of Leprosy and other Mycobacterial Diseases: Official Organ of the International Leprosy Association 54(1): 57-62

Bakowski, M.T. 1976: ICRF 159, (+/-) 1,2-di(3,5-dioxopiperazin-1-yl) propane NSC-129,943; razoxane. Cancer Treatment Reviews 3(2): 95-107

Hellmann, K.; Rieche, K. 1978: ICRF 159--a cytostatic substance. Deutsche Medizinische Wochenschrift 103(41): 1621

Tryka, A.F. 1989: ICRF 187 and polyhydroxyphenyl derivatives fail to protect against bleomycin induced lung injury. Toxicology 59(2): 127-138

Price, L.A. 1988: ICRF appeals. Lancet 2(8625): 1429

Homesley, H.D.; Blessing, J.A.; Conroy, J.; Hatch, K.; DiSaia, P.J.; Twiggs, L.B. 1986: ICRF-159 (razoxane) in patients with advanced adenocarcinoma of the endometrium. a Gynecologic Oncology Group Study. American Journal of Clinical Oncology 9(1): 15-17

Homesley, H.D.; Blessing, J.A.; Berman, M. 1986: ICRF-159 (razoxane) in patients with advanced nonsquamous cell carcinoma of the cervix. a Gynecologic Oncology Group study. American Journal of Clinical Oncology 9(4): 325-326

Dyment, P.G.; Starling, K.A.; Land, V.J.; Cangir, A.; Komp, D.M.; Sexauer, C.L. 1979: ICRF-159 (razoxane) in the treatment of pediatric solid tumors: a Southwest Oncology Group study. Cancer Treatment Reports 63(8): 1397-1398

Bellet, R.E.; Rozencweig, M.; Von Hoff, D.D.; Penta, J.S.; Wasserman, T.H.; Muggia, F.M. 1977: ICRF-159: current status and clinical prospects. European Journal of Cancer 13(11): 1293-1298

Green, M.D.; Alderton, P.; Sobol, M.M.; Gross, J.; Muggia, F.M.; Speyer, J.L. 1991: ICRF-187 (ADR-529) cardioprotection against anthracycline-induced cardiotoxicity: clinical and preclinical studies. Cancer Treatment and Research 58: 101-117

Anonymous 1989: ICRF-187 and doxorubicin-induced cardiac toxicity. New England Journal of Medicine 320(6): 399-400

Anonymous 1987: ICRF-187 and razoxane in cancer treatment. Lancet 2(8561): 721

Speyer, J.L.; Green, M.D.; Zeleniuch-Jacquotte, A.; Wernz, J.C.; Rey, M.; Sanger, J.; Kramer, E.; Ferrans, V.; Hochster, H.; Meyers, M. 1992: ICRF-187 permits longer treatment with doxorubicin in women with breast cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 10(1): 117-127

Nagaratham, A. 1978: ICRP 1977 recommendations and handling of radionuclide generators. British Journal of Radiology 51(611): 931

Harding, K. 1991: ICRP 60 and future legislation. Nuclear Medicine Communications 12(9): 753-755

Ambiger, T.Y.; Iyer, P.S. 1979: ICRP Publication 26 and the "ten-day rule". Health Physics 36(3): 471

Smith, H. 1988: ICRP Publication 50: lung cancer risk from indoor exposures to radon daughters. Canadian Association of Radiologists Journal 39(2): 144

Sowby, D. 1986: ICRP recommendations for radioprotection of the skin: history and present status. British Journal of Radiology. Suppl 19: 138-141

Dang, H.S.; Jaiswal, D.D.; Sharma, R.C. 1992: ICRP recommendations of the derived thorium excretion levels for occupational workers--a viewpoint. Health Physics 63(5): 592-593

Wyckoff, H.O. 1978: ICRU and ICRP activities are important to radiologists and allied scientists. Radiology 129(2): 537-538

Küster, W.; Hofner, W.; Wicke, L.; Kühböck, J. 1978: Varicella pneumonia in a patient with Hodgkin's disease. Der Radiologe 18(10): 398-400

Hrupka, B.J.; Gietzen, D.W.; Beverly, J.L. 1991: ICS 205-930 and feeding responses to amino acid imbalance: a peripheral effect?. Pharmacology Biochemistry and Behavior 40(1): 83-87

Freydberg, B. 1989: ICS system part of broader office management approach. Dentist 67(7): 10

Delorme, M.A.; Inwood, M.J.; O'Keefe, B. 1990: Sensitivity of the thrombin clotting time and activated partial thromboplastin time to low level of antithrombin IIi during heparin therapy. Clinical and Laboratory Haematology 12(4): 433-436

Schmidt, R.M. 1975: ICSH-ISTH International Anticoagulant Control Study. I. Background and co-ordination. Thrombosis et Diathesis Haemorrhagica 34(1): 363

Hills, M. 1975: ICSH-ISTH International Anticoagulant Control Study. II. Design and findings. Thrombosis et Diathesis Haemorrhagica 34(1): 363

Ingram, G.I. 1975: ICSH-ISTH International Anticoagulant Control Study. III. Implications of the findings. Thrombosis et Diathesis Haemorrhagica 34(1): 361-362

Torlontano, G.; Iacone, A.; Di Bartolomeo, P.; Di Girolamo, G.; Natale, D.; Bonanni, G. 1985: Therapy of thalassemia major with transplant of the bone marrow. our experience with the busulfan, cyclophosphamide, cyclosporin, and acyclovir protocol. Haematologica 70(3): 270-271

Indran, M.; Boyle, F.C.; Carr, K.E. 1985: Simulation with pharmacological agents of radiation damage to small intestinal villi. Scanning Electron Microscopy 45(Part 3): 1165-1175

Theaker, J.M.; Gatter, K.C.; Heryet, A.; Evans, D.J.; McGee, J.O. 1985: Giant cell myocarditis: evidence for the macrophage origin of the giant cells. Journal of Clinical Pathology 38(2): 160-164

Harris, J.R.; Osteen, R.T. 1985: Patients with early breast cancer benefit from effective axillary treatment. Breast Cancer Research and Treatment 5(1): 17-21

Von dem Borne, A.E.; Décary, F. 1990: ICSH/ISBT Working Party on platelet serology. Nomenclature of platelet-specific antigens. Vox Sanguinis 58(2): 176

Boissel, J.P. 1986: ICTH(International Committee on Haemostasis and Thrombosis)--Sub committee on Clinical Trials. Registry of Multicenter Clinical Trials. Seventh Report--1985. Thrombosis and Haemostasis 55(2): 282-291

Franklin, C.; Rackow, E.C. 1989: ICU access and prospective payment. JAMA 261(17): 2500

Sanders, J.B. 1986: ICU admission and discharge screening criteria. Nursing Administration Quarterly 10(3): 25-31

Sabo, K.A.; Kraay, C.; Rudy, E.; Abraham, T.; Bender, M.; Lewandowski, W.; Lombardo, B.; Turk, M.; Dawson, D. 1989: ICU family support group sessions: family members' perceived benefits. Applied Nursing Research: Anr 2(2): 82-89

Fracassi, J. 1987: ICU flowsheets: are they cost-effective?. Nursing Management 18(12): 66-67

Björck, S. 1977: ICU in Norköping: we can't ever finish patient care. Vardfacket 1(9): 4-7

Gray, A.G.; Morgan, J.; Linch, D.C.; Huehns, E.R. 1989: Enhanced fluorescence in indirect immunophenotyping by the use of fluorescent liposomes. Journal of Immunological Methods 121(1): 1-7

Trozell, M. 1987: ICU job provides us with fellowship and wide knowledge. Vardfacket 11(17): 6-8

Popp, A.J.; Feustel, P.J.; Fortune, J.B. 1989: ICU management of pulmonary dysfunction in neurosurgical patients. Clinical Neurosurgery 35: 71-92

Mitchell, R.R.; Wilson, R.M.; Sierra, D. 1986: ICU monitoring of ventilation distribution. International Journal of Clinical Monitoring and Computing 2(4): 199-206

Baggs, J.G.; Ryan, S.A. 1990: ICU nurse-physician collaboration and nursing satisfaction. Nursing Economic\$ 8(6): 386-392

Lewis, D.J.; Robinson, J.A. 1992: ICU nurses' coping measures: response to work-related stressors. Critical Care Nurse 12(2): 18-23

Yasuda, H.; Narita, N.; Kaneda, T.; Kanazawa, K.; Narita, I. 1985: ICU nursing following coronary artery surgery. Nursing Technique 31(7): 956-959

Kishida, C.; Narita, I.; Kimura, S. 1985: ICU nursing following replacement with artificial valves. Nursing Technique 31(8): 1097-1100

Sato, M.; Ito, A. 1977: ICU nursing--practice at Kitasato University Hospital. 6. Nursing of patients with respiratory insufficiency (2). Kangogaku Zasshi 41(6): 612-614

Kamishima, Y. 1977: ICU nursing--practice at Kitasato University Hospital. 7. Nursing of a patient with respiratory disease. Kangogaku Zasshi 41(7): 729-732

Anonymous 1986: ICU patient's life depends on how well RNs, MDs get along. American Nurse 18(8): 1 16

Zawacki, B.E. 1985: ICU physician's ethical role in distributing scarce resources. Critical Care Medicine 13(1): 57-60

Ruiz-Santana, S.; García Jimenez, A.; Esteban, A.; Guerra, L.; Alvarez, B.; Corcia, S.; Gudin, J.; Martinez, A.; Quintana, E.; Armengol, S. 1987: ICU pneumonias: a multi-institutional study. Critical Care Medicine 15(10): 930-932

Diekstra, R.F.; Stubbé, L.T.; Willemsteyn, B. 1986: ICU sensory deprivation. Nursing Success Today 3(6): 21-25

Tinsley, A.; Hurst, K. 1990: ICU staffing, skill mix, and bed occupancy. Nursing Times 86(32): 52-53

Schein, R.M.; Fischl, M.A.; Pitchenik, A.E.; Sprung, C.L. 1986: ICU survival of patients with the acquired immunodeficiency syndrome. Critical Care Medicine 14(12): 1026-1027

Mayumi, T.; Kemmotsu, O.; Fukuda, M.; Saito, Y.; Katayama, K. 1992: ICU syndrome. Hokkaido Journal of Medical Science 67(1): 1-11

Risenmay, A. 1986: ICU syndrome: a literature review. One on one 8(2): 11-13

Rosenthal, K.A. 1992: ICU-CCU flowsheet. Critical Care Nurse 12(8): 58-62

Gómez-Sánchez, E.P.; Venkataraman, M.T.; Thwaites, D.; Fort, C. 1990: ICV infusion of corticosterone antagonizes ICV-aldosterone hypertension. American Journal of Physiology 258(4 Part 1): E649-E653

Sherman, J.E.; Kalin, N.H. 1988: ICV-CRH alters stress-induced freezing behavior without affecting pain sensitivity. Pharmacology Biochemistry and Behavior 30(4): 801-807

Sherman, J.E.; Kalin, N.H. 1986: ICV-CRH potently affects behavior without altering antinociceptive responding. Life Sciences 39(5): 433-441

Marcus, A.C.; Baker, D.B.; Froines, J.R.; Brown, E.R.; McQuiston, T.; Herman, N.A. 1986: ICWU cancer control education and evaluation program: research design and needs assessment. Journal of Occupational Medicine.: Official Publication of the Industrial Medical Association 28(3): 226-236

Anzai, K.; Goto, S. 1988: ID sequence-binding protein factor complexed in ribonucleoprotein particles. Neuroscience Letters 89(2): 246-250

Anzai, K.; Goto, S. 1988: ID sequence-binding protein factors during development of mice. Brain Research 464(4): 273-281

Usui, H.; Kuwano, R.; Maeda, T.; Araki, K.; Sakimura, K.; Kushiya, E.; Takahashi, Y. 1987: ID sequences in the genes of three brain-specific proteins. Biochemistry International 15(4): 809-816

Korotkov, E.V.; Mamaeva, E.F. 1989: ID-similar sequences in various types of DNA clones. Molekuliarnaia Biologiia 23(4): 1113-1123

Majer, M.; Hilfenhaus, J.; Mauler, R.; Hennessen, W. 1975: Zonal-centrifuged human diploid cell rabies vaccine. Developments in Biological Standardization 37(3): 267-271

Dorman, J.S.; LaPorte, R.E. 1990: IDDM epidemiology. Next generation of research. Diabetes Care 13(2): 184-185

Ono, S.J.; Issa-Chergui, B.; Colle, E.; Guttmann, R.D.; Seemayer, T.A.; Fuks, A. 1988: IDDM in BB rats. Enhanced MHC class i heavy-chain gene expression in pancreatic islets. Diabetes 37(10): 1411-1418

Quatraro, A. 1987: IDDM treatment with single dose of mixture of three kinds of insulin: 2-yr follow-up. Diabetes Care 10(3): 379-380

MacGregor, A.J.; Long, A.F.; Mercer, P.E. 1991: IDEA: an index of dental educational activity. Medical Education 25(4): 349-355

Welsby, P.D.; Geddes, A.M.; Lambert, H.P.; Fallon, R.J. 1989: IDEA: infectious diseases eradication adviser. Journal of Antimicrobial ChemoTherapy 23(5): 812-813

Wanke, L.A. 1977: IDIS self-instructional guide. American Journal of Hospital Pharmacy 34(12): 1307-1308

Nordestgaard, B.G.; Tybjaerg-Hansen, A. 1992: IDL, VLDL, chylomicrons and atherosclerosis. European Journal of Epidemiology 8(Suppl 1): 92-98

Bratthall, D. 1992: IDP--the International Development Programme. Dental World 1992(3): 18-19

Anonymous 1987: IDPH survey of Illinois adults. Awareness and attitudes about AIDS. Illinois Medical Journal 171(6): 392-393

Davis, S. 1988: IDS program opens up a whole new world. Contact Point 66(1): 11-13

Pursell, K.J.; Telzak, E.E.; Armstrong, D. 1992: Aspergillus species colonization and invasive disease in patients with AIDS. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 14(1): 141-148

Hornick, R.B. 1987: IDSA--past, present, and future?. Journal of Infectious Diseases 155(3): 343-348

Angra, S.K. 1977: IDU ocular toxicity. Indian Journal of Ophthalmology 25(2): 38-41

Wälti, M.; Neftel, K.A.; Jost, R.; Jaeger, A.; Berg, P.; Heinzel, F.; Weitzel, M. 1986: IE and IgG antibodies against flavonoids following therapy with flavonoid-containing drugs. Schweizerische Medizinische Wochenschrift 116(4): 98-103

Ma, T.Y.; Hollander, D.; Bhalla, D.; Nguyen, H.; Krugliak, P. 1992: IEC-18, a nontransformed small intestinal cell line for studying epithelial permeability. Journal of Laboratory and Clinical Medicine 120(2): 329-341

Crepaldi, T.; D'Alfonso, S.; Richiardi, P. 1990: IEF analysis of HLA molecules immunoprecipitated by putative anti-class I-like alloantisera. Journal of Immunogenetics 17(6): 409-413

Yang, S.Y.; Chang, A.; Olivero, R.; Relias, V.; Yunis, E.J. 1985: IEF patterns of HLA-B13 antigens from Orientals and Caucasians. Immunogenetics 21(2): 125-134

Megow, D.; Krätschmer, J.; Jacobasch, G. 1990: IEF-microheterogeneity of human PK-R: applicability for prenatal diagnosis. Biomedica Biochimica Acta 49(2-3): S305-S308

Bronks, R.; Brown, J.M. 1987: IEMG/force relationships in rapidly contracting human hand muscles. Electromyography and Clinical Neurophysiology 27(8): 509-515

Goldberg, L.S. 1976: IES Arrow-Dot longitudinal comparisons of personality development in preschool children. Perceptual and Motor Skills 42(3): 929-930

Goldberg, L.S. 1975: IES Arrow-Dot longitudinal study of personality development in preschool children. Perceptual and Motor Skills 40(1): 209-210

Krech, U.; Jung, M.; Pyndiah, N.; Price, P.C. 1976: IF-40. A new polystyrene microscope tray for immunofluorescent studies. Zentralblatt für Bakteriologie Parasitenkunde Infektionskrankheiten und Hygiene. Erste Abteilung Originale. Reihe A: Medizinische Mikrobiologie und Parasitologie 234(1): 136-140

Di Pietro, A.; Penin, F.; Julliard, J.H.; Godinot, C.; Gautheron, D.C. 1988: IF1 inhibition of mitochondrial F1-ATPase is correlated to entrapment of four adenine- or guanine-nucleotides including at least one triphosphate. Biochemical and Biophysical Research Communications 152(3): 1319-1325

Edrissian, G.H.; Ghorbani, M.; Afshar, A. 1985: IFA serological surveys of malaria in north, north-west and south-west parts of Iran. Bulletin de la Societe de Pathologie Exotique et de Ses Filiales 78(3): 349-359

Nakalov, F.S.; Ozerov, V.D.; Dement'eva, Z.A. 1978: IFAM-1 indicator of microorganism enzymatic activity. Meditsinskaia Tekhnika 2: 48-49

Burnett, R.W.; Covington, A.K.; Maas, A.H.; Müller-Plathe, O.; Weisberg, H.F.; Wimberley, P.D.; Zijlstra, W.G.; Siggaard-Anderson, O.; Durst, R.A. 1989: IFCC document stage 3, draft 1, dated 1989 02 01. An approved IFCC recommendation. IFCC method (1988) for tonometry of blood: reference materials for pCO2 and pO2. International Federation of Clinical Chemistry Scientific Division. Committee on pH, Blood Gases and Electrolytes. Clinica Chimica Acta; International Journal of Clinical Chemistry 185(1): S17-S24

Doumas, B.T. 1979: IFCC documents and interpretation of Si units--a solution looking for a problem. Clinical Chemistry 25(5): 655-658

Bergmeyer, H.U.; Bowers, G.N.; Horder, M.; Moss, D.W. 1976: IFCC method for aspartate aminotransferase. Appendix B. Conditions for the measurement of the catalytic concentrations of reagent enzymes and the contaminants. Clinica Chimica Acta; International Journal of Clinical Chemistry 70(2): F41-F42

Arzate, H.; Olson, S.W.; Page, R.C.; Narayanan, A.S. 1992: Isolation of human tumor cells that produce cementum proteins in culture. Bone and Mineral 18(1): 15-30

Kemp, G.E.; Le Gonidec, G.; Karabatsos, N.; Rickenbach, A.; Cropp, C.B. 1988: IFE: a new African orbivirus isolated from Eidolon helvum bats captured in Nigeria, Cameroon and the Central African Republic. Bulletin de la Societe de Pathologie Exotique et de Ses Filiales 81(1): 40-48

Cotti, Q.F. 1986: IFGA in pain of patients with neoplasms in the terminal phase. Amb: Revista da Associacao Medica Brasileira 32(9-10): 184

Gilson, J. 1990: IFMC case notes. Outlier review. Iowa Medicine: Journal of the Iowa Medical Society 80(6): 309

Stahl, J. 1990: IFMC case notes. Private review. Iowa Medicine: Journal of the Iowa Medical Society 80(8): 402

Thomson, I.S.; Wills, L.C. 1976: A prospective study of children "at risk" for deafness. Journal of Laryngology and Otology 90(2): 167-172

Gauldie, J.; Richards, C.; Northemann, W.; Fey, G.; Baumann, H. 1989: IFN beta 2/BSF2/IL-6 is the monocyte-derived HSF that regulates receptor-specific acute phase gene regulation in hepatocytes. Annals of the new York Academy of Sciences 557: 46-58; Discussion: 58-59

Perlmutter, D.H. 1989: IFN beta 2/IL-6 is one of several cytokines that modulate acute phase gene expression in human hepatocytes and human macrophages. Annals of the new York Academy of Sciences 557: 332-341; Discussion: 341-342

Bruchelt, G.; Treuner, J.; Beck, J.; Schilling, F.; Koscielniak, E.; Niethammer, D. 1985: IFN gamma potentiates the induction of (2-5)A-synthetase in human tumor cells treated with IFN alpha and beta. Progress in Clinical and Biological Research 202: 391-395

Kikuta, H. 1986: IFN production by Epstein-Barr virus in human mononuclear leukocytes and suppression of the virus-induced transformation by the endogenous interferon. Hokkaido Journal of Medical Science 61(1): 46-57

Webb, D.S.; Gerrard, T.L. 1990: IFN-alpha and IFN-gamma can affect both monocytes and tumor cells to modulate monocyte-mediated cytotoxicity. Journal of Immunology 144(9): 3643-3648

Te Velde, A.A.; Rousset, F.; Peronne, C.; De Vries, J.E.; Figdor, C.G. 1990: IFN-alpha and IFN-gamma have different regulatory effects on IL-4-induced membrane expression of Fc epsilon RIIb and release of soluble Fc epsilon RIIb by human monocytes. Journal of Immunology 144(8): 3052-3059

Billard, C.; Sigaux, F.; Wietzerbin, J. 1990: IFN-alpha in vivo enhances tumor necrosis factor receptor levels on hairy cells. Journal of Immunology 145(6): 1713-1718

Horisberger, M.A.; Hochkeppel, H.K. 1987: IFN-alpha induced human 78 kD protein: purification and homologies with the mouse Mx protein, production of monoclonal antibodies, and potentiation effect of IFN-gamma. Journal of Interferon Research 7(4): 331-343

Jourdan, M.; Zhang, X.G.; Portier, M.; Boiron, J.M.; Bataille, R.; Klein, B. 1991: IFN-alpha induces autocrine production of IL-6 in myeloma cell lines. Journal of Immunology 147(12): 4402-4407

Liberati, A.M.; Schippa, M.; Portuesi, M.G.; Grazia Proietti, M.; De Angelis, V.; Ferrajoli, A.; Cinieri, S.; Di Clemente, F.; Palmisano, L.; Berruto, P. 1991: IFN-beta induced biochemical and immunological modifications in hairy cell leukemia patients. Haematologica 76(5): 375-382

Cleveland, M.G.; Ramirez, R.B.; Klimpel, G.R. 1988: IFN-beta production by macrophages obtained from mice undergoing graft vs host disease. Journal of Immunology 141(11): 3823-3827

Vey, E.; Zhang, J.H.; Dayer, J.M. 1992: IFN-gamma and 1,25(OH)2D3 induce on THP-1 cells distinct patterns of cell surface antigen expression, cytokine production, and responsiveness to contact with activated T cells. Journal of Immunology 149(6): 2040-2046

Abbott, R.J.; Bolderson, I.; Gruer, P.J. 1985: IFN-gamma and IFN-alpha in CSF in viral meningitis. Lancet 2(8452): 456-457

Jaffe, E.A.; Armellino, D.; Lam, G.; Cordon-Cardo, C.; Murray, H.W.; Evans, R.L. 1989: IFN-gamma and IFN-alpha induce the expression and synthesis of Leu 13 antigen by cultured human endothelial cells. Journal of Immunology 143(12): 3961-3966

Hamilton, T.A.; Bredon, N.; Ohmori, Y.; Tannenbaum, C.S. 1989: IFN-gamma and IFN-beta independently stimulate the expression of lipopolysaccharide-inducible genes in murine peritoneal macrophages. Journal of Immunology 142(7): 2325-2331

Narumi, S.; Tebo, J.M.; Finke, J.H.; Hamilton, T.A. 1992: IFN-gamma and IL-2 cooperatively activate NF kappa B in murine peritoneal macrophages. Journal of Immunology 149(2): 529-534

Szefler, S.J.; Norton, C.E.; Ball, B.; Gross, J.M.; Aida, Y.; Pabst, M.J. 1989: IFN-gamma and LPS overcome glucocorticoid inhibition of priming for superoxide release in human monocytes. Evidence that secretion of IL-1 and tumor necrosis factor-alpha is not essential for monocyte priming. Journal of Immunology 142(11): 3985-3992

Olobo, J.O.; Reid, G.D.; Githure, J.I.; Anjili, C.O. 1992: IFN-gamma and delayed-type hypersensitivity are associated with cutaneous leishmaniasis in vervet monkeys following secondary rechallenge with Leishmania major. Scandinavian Journal of Immunology. Suppl 11: 48-52

Galizzi, J.P.; Cabrillat, H.; Rousset, F.; Ménétrier, C.; de Vries, J.E.; Banchereau, J. 1988: IFN-gamma and prostaglandin E2 inhibit IL-4-induced expression of Fc epsilon R2/CD23 on B lymphocytes through different mechanisms without altering binding of IL-4 to its receptor. Journal of Immunology 141(6): 1982-1988

Bauvois, B.; Rouillard, D.; Sanceau, J.; Wietzerbin, J. 1992: IFN-gamma and transforming growth factor-beta 1 differently regulate fibronectin and laminin receptors of human differentiating monocytic cells. Journal of Immunology 148(12): 3912-3919

Campbell, I.L.; Iscaro, A.; Harrison, L.C. 1988: IFN-gamma and tumor necrosis factor-alpha. Cytotoxicity to murine islets of Langerhans. Journal of Immunology 141(7): 2325-2329

Klein, J.B.; Scherzer, J.A.; McLeish, K.R. 1992: IFN-gamma enhances expression of formyl peptide receptors and guanine nucleotide-binding proteins by HL-60 granulocytes. Journal of Immunology 148(8): 2483-2488

Bossie, A.; Vitetta, E.S. 1991: IFN-gamma enhances secretion of IgG2a from IgG2a-committed LPS-stimulated murine B cells: implications for the role of IFN-gamma in class switching. Cellular Immunology 135(1): 95-104

Blanchard, D.K.; McMillen, S.; Djeu, J.Y. 1991: IFN-gamma enhances sensitivity of human macrophages to extracellular ATP-mediated lysis. Journal of Immunology 147(8): 2579-2585

Nakamura, M.; Ogawa, H.; Tsunematsu, T. 1992: IFN-gamma enhances the expression of cell surface receptors for monoclonal nonspecific suppressor factor. Cellular Immunology 139(1): 131-138

Improta, T.; Salvatore, A.M.; Di Luzio, A.; Romeo, G.; Coccia, E.M.; Calissano, P. 1988: IFN-gamma facilitates NGF-induced neuronal differentiation in PC12 cells. Experimental Cell Research 179(1): 1-9

Campbell, I.L.; Oxbrow, L.; Koulmanda, M.; Harrison, L.C. 1988: IFN-gamma induces islet cell MHC antigens and enhances autoimmune, streptozotocin-induced diabetes in the mouse. Journal of Immunology 140(4): 1111-1116

Celada, A.; Maki, R.A. 1991: IFN-gamma induces the expression of the genes for MHC class Ii I-A beta and tumor necrosis factor through a protein kinase C-independent pathway. Journal of Immunology 146(1): 114-120

Harel-Bellan, A.; Brini, A.T.; Farrar, W.L. 1988: IFN-gamma inhibits c-myc gene expression by impairing the splicing process in a colony-stimulating factor dependent murine myeloid cell line. Journal of Immunology 141(3): 1012-1017

Mellouk, S.; Green, S.J.; Nacy, C.A.; Hoffman, S.L. 1991: IFN-gamma inhibits development of Plasmodium berghei exoerythrocytic stages in hepatocytes by an L-arginine-dependent effector mechanism. Journal of Immunology 146(11): 3971-3976

Wahl, S.M.; Allen, J.B.; Ohura, K.; Chenoweth, D.E.; Hand, A.R. 1991: IFN-gamma inhibits inflammatory cell recruitment and the evolution of bacterial cell wall-induced arthritis. Journal of Immunology 146(1): 95-100

Sanceau, J.; Beranger, F.; Gaudelet, C.; Wietzerbin, J. 1989: IFN-gamma is an essential cosignal for triggering IFN-beta 2/BSF-2/IL-6 gene expression in human monocytic cell lines. Annals of the new York Academy of Sciences 557: 130-41; Discussion: 141-143

Latta, S.L.; Eisenberg, L.; Spitalny, G.L.; Quintans, J. 1987: IFN-gamma is not an essential mediator of murine antibody responses in vitro. Immunology Letters 14(4): 355-358

Laskay, T.; Hansson, M.; Porwit, A.; Björkholm, M.; Berthold, W.; Kiessling, R. 1987: IFN-gamma is not the only mediator of suppressed myelopoiesis produced by mononuclear cells from aplastic anemia patients. Journal of Biological Regulators and Homeostatic Agents 1(1): 37-44

Takikawa, O.; Habara-Ohkubo, A.; Yoshida, R. 1990: IFN-gamma is the inducer of indoleamine 2,3-dioxygenase in allografted tumor cells undergoing rejection. Journal of Immunology 145(4): 1246-1250

Salkowski, C.A.; Vogel, S.N. 1992: IFN-gamma mediates increased glucocorticoid receptor expression in murine macrophages. Journal of Immunology 148(9): 2770-2777

Scott, P. 1991: IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis. Journal of Immunology 147(9): 3149-3155

Morganelli, P.M.; Guyre, P.M. 1988: IFN-gamma plus glucocorticoids stimulate the expression of a newly identified human mononuclear phagocyte-specific antigen. Journal of Immunology 140(7): 2296-2304

Sebaldt, R.J.; Prpic, V.; Hollenbach, P.W.; Adams, D.O.; Uhing, R.J. 1990: IFN-gamma potentiates the accumulation of diacylglycerol in murine macrophages. Journal of Immunology 145(2): 684-689

Gessner, A.; Drjupin, R.; Löhler, J.; Lother, H.; Lehmann-Grube, F. 1990: IFN-gamma production in tissues of mice during acute infection with lymphocytic choriomeningitis virus. Journal of Immunology 144(8): 3160-3165

Berkovic, D.; Bartsch, H.H.; Scheurich, P.; Ucer, U.; Pfizenmaier, K. 1986: IFN-gamma receptors on human tumor cells: relationship between receptor ligand interactions and induction of IFN-gamma response. Immunobiology 172(3-5): 243-249

Drapier, J.C.; Wietzerbin, J. 1991: IFN-gamma reduces specific binding of tumor necrosis factor on murine macrophages. Journal of Immunology 146(4): 1198-1203

Leeuwenberg, J.F.; von Asmuth, E.J.; Jeunhomme, T.M.; Buurman, W.A. 1990: IFN-gamma regulates the expression of the adhesion molecule ELAM-1 and IL-6 production by human endothelial cells in vitro. Journal of Immunology 145(7): 2110-2114

Finkelman, F.D.; Katona, I.M.; Mosmann, T.R.; Coffman, R.L. 1988: IFN-gamma regulates the isotypes of Ig secreted during in vivo humoral immune responses. Journal of Immunology 140(4): 1022-1027

Guha, A.; Cone, R.E. 1991: IFN-gamma retards the turnover of H-2Dd antigens by splenic lymphocytes. Journal of Immunology 146(6): 1858-1861

Plum, J.; De Smedt, M.; Billiau, A.; Heremans, H.; Leclercq, G.; Tison, B. 1991: IFN-gamma reverses IL-4 inhibition of fetal thymus growth in organ culture. Journal of Immunology 147(1): 50-54

Snapper, C.M.; Peschel, C.; Paul, W.E. 1988: IFN-gamma stimulates IgG2a secretion by murine B cells stimulated with bacterial lipopolysaccharide. Journal of Immunology 140(7): 2121-2127

Fuchs, D.; Reibnegger, G.; Werner-Felmayer, G.; Dierich, M.P.; Wachter, H. 1991: IFN-gamma to treat patients with AIDS. Journal of Acquired Immune Deficiency Syndromes 4(3): 297-300

Grönberg, A.; Ferm, M.T.; Ng, J.; Reynolds, C.W.; Ortaldo, J.R. 1988: IFN-gamma treatment of K562 cells inhibits natural killer cell triggering and decreases the susceptibility to lysis by cytoplasmic granules from large granular lymphocytes. Journal of Immunology 140(12): 4397-4402

Kirchheimer, J.C.; Nong, Y.H.; Remold, H.G. 1988: IFN-gamma, tumor necrosis factor-alpha, and urokinase regulate the expression of urokinase receptors on human monocytes. Journal of Immunology 141(12): 4229-4234

Kelly, E.A.; Cruz, E.S.; Hauda, K.M.; Wassom, D.L. 1991: IFN-gamma- and IL-5-producing cells compartmentalize to different lymphoid organs in Trichinella spiralis-infected mice. Journal of Immunology 147(1): 306-311

Nash, T.W.; Libby, D.M.; Horwitz, M.A. 1988: IFN-gamma-activated human alveolar macrophages inhibit the intracellular multiplication of Legionella pneumophila. Journal of Immunology 140(11): 3978-3981

Pellat, C.; Henry, Y.; Drapier, J.C. 1990: IFN-gamma-activated macrophages: detection by electron paramagnetic resonance of complexes between L-arginine-derived nitric oxide and non-heme iron proteins. Biochemical and Biophysical Research Communications 166(1): 119-125

Langermans, J.A.; Van der Hulst, M.E.; Nibbering, P.H.; Hiemstra, P.S.; Fransen, L.; Van Furth, R. 1992: IFN-gamma-induced L-arginine-dependent toxoplasmastatic activity in murine peritoneal macrophages is mediated by endogenous tumor necrosis factor-alpha. Journal of Immunology 148(2): 568-574

Kildahl-Andersen, O.; Espevik, T.; Nissen-Meyer, J. 1985: IFN-gamma-induced production of monocyte cytotoxic factor. Cellular Immunology 95(2): 392-406

Kawamura, I.; Tsukada, H.; Yoshikawa, H.; Fujita, M.; Nomoto, K.; Mitsuyama, M. 1992: IFN-gamma-producing ability as a possible marker for the protective T cells against Mycobacterium bovis BCG in mice. Journal of Immunology 148(9): 2887-2893

Real, F.X.; Carrato, A.; Schuessler, M.H.; Welt, S.; Oettgen, H.F. 1988: IFN-gamma-regulated expression of a differentiation antigen of human cells. Journal of Immunology 140(5): 1571-1576

Knight, E.; Cordova, B. 1991: IFN-induced 15-kDa protein is released from human lymphocytes and monocytes. Journal of Immunology 146(7): 2280-2284

Hokland, M.; Basse, P.; Justesen, J.; Hokland, P. 1988: IFN-induced modulation of histocompatibility antigens on human cells. Background, mechanisms and perspectives. Cancer Metastasis Reviews 7(3): 193-207

Hakem, R.; Le Bouteiller, P.; Barad, M.; Trujillo, M.; Mercier, P.; Wietzerbin, J.; Lemonnier, F.A. 1989: IFN-mediated differential regulation of the expression of HLA-B7 and HLA-A3 class i genes. Journal of Immunology 142(1): 297-305

Niederwieser, D.; Auböck, J.; Troppmair, J.; Herold, M.; Schuler, G.; Boeck, G.; Lotz, J.; Fritsch, P.; Huber, C. 1988: IFN-mediated induction of MHC antigen expression on human keratinocytes and its influence on in vitro alloimmune responses. Journal of Immunology 140(8): 2556-2564

Altboum, I.; Porat, Y.; Zan-Bar, I. 1992: IFN-tau induces CD5+ lymphoma B-cell line 29M10 to differentiate to IgG1-bearing cells and to secrete IgG1 isotype. Annals of the new York Academy of Sciences 651: 152-154

Main, E.K.; Monos, D.S.; Lampson, L.A. 1988: IFN-treated neuroblastoma cell lines remain resistant to T cell-mediated allo-killing, and susceptible to non-MHC-restricted cytotoxicity. Journal of Immunology 141(9): 2943-2950

Zöller, M. 1988: IFN-treatment of B16-F1 versus B16-F10: relative impact on non-adaptive and T-cell-mediated immune defense in metastatic spread. Clinical and Experimental Metastasis 6(5): 411-429

Weerasuriya, K. 1991: IFPMA code on advertising. Lancet 337(8734): 178

Cooke, M.A. 1991: IFRA and the dermatologist. Contact Dermatitis 25(4): 209-210

Akhmedkhodzhaeva, N.M.; Khalmatov, K.K. 1979: Possibility of standardizing Sophora infusions by the content of phenol compounds. Farmatsevtychnyi Zhurnal 11(6): 32-34

Robinson, M.L. 1988: IG cites bad debt, unnecessary admissions. Hospitals 62(10): 24-26

Robinson, M.L. 1988: IG report: PROs need more direction. Hospitals 62(8): 18-19

Hayem, A.; Laine, A.; Kopaczewski, A.; Lafitte, J.J. 1979: IGA 7S/ IGA 11S ratio in broncho-alveolar washings. La Nouvelle Presse Medicale 8(25): 2119-2120

Arndt, M. 1976: IGA and IGE in bronchial asthma of the child. Monatsschrift für Kinderheilkunde 124(5): 256-257

Mustonen, J.; Helin, H.; Pasternack, A. 1979: IGA nephropathy. Duodecim; Laaketieteellinen Aikakauskirja 95(24): 1657-1665

Tolkoff-Rubin, N.E.; Cosimi, A.B.; Fuller, T.; Rublin, R.H.; Colvin, R.B. 1978: IGA nephropathy in HLA-identical siblings. Transplantation 26(6): 430-433

Horiuchi, Y. 1977: IGE and etiology of atopic diseases. Nihon Rinsho. Japanese Journal of Clinical Medicine 35(4): 1645-1652

De Blay, F.; Sager, M.F.; Hirth, C.; Alt, M.; Chamouard, P.; Baumann, R.; Pauli, G. 1992: IGE-mediated reaction to hydroxocobalamin injection in patient with pernicious anaemia. Lancet 339(8808): 1535-1536

Klempt, M.; Hutchins, A.M.; Gluckman, P.D.; Skinner, S.J. 1992: IGF binding protein-2 gene expression and the location of IGF-i and IGF-Ii in fetal rat lung. Development 115(3): 765-772

Lee, P.D.; Hintz, R.L.; Sperry, J.B.; Baxter, R.C.; Powell, D.R. 1989: IGF binding proteins in growth-retarded children with chronic renal failure. Pediatric Research 26(4): 308-315

Clemmons, D.R. 1992: IGF binding proteins: regulation of cellular actions. Growth Regulation 2(2): 80-87

Caverzasio, J.; Bonjour, J.P. 1992: IGF-1 and phosphate homeostasis during growth. Nephrologie 13(3): 109-113

Wilden, P.A.; Treadway, J.L.; Morrison, B.D.; Pessin, J.E. 1989: IGF-1-dependent subunit communication of the IGF-1 holoreceptor: interactions between alpha beta heterodimeric receptor halves. Biochemistry 28(25): 9734-9740

Harvey, M.B.; Kaye, P.L. 1991: IGF-2 receptors are first expressed at the 2-cell stage of mouse development. Development 111(4): 1057-1060

Tally, M.; Li, C.H.; Hall, K. 1987: IGF-2 stimulated growth mediated by the somatomedin type 2 receptor. Biochemical and Biophysical Research Communications 148(2): 811-816

Bach, L.A. 1992: IGF-i and IGF binding proteins in diabetes-related kidney growth. Growth Regulation 2(1): 30-39

Singh, P.; Guo, Y.S.; Narayan, S.; Chandrasekhar, Y. 1991: IGF-I and IGF-I receptor in mouse colon cancer cells. In Vitro Cellular and Developmental Biology; Journal of the Tissue Culture Association 27(10): 755-758

Brünner, N.; Moser, C.; Clarke, R.; Cullen, K. 1992: IGF-i and IGF-Ii expression in human breast cancer xenografts: relationship to hormone independence. Breast Cancer Research and Treatment 22(1): 39-45

Cheng, B.; Mattson, M.P. 1992: IGF-i and IGF-Ii protect cultured hippocampal and septal neurons against calcium-mediated hypoglycemic damage. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 12(4): 1558-1566

Kaicer, E.K.; Blat, C.; Harel, L. 1991: IGF-i and IGF-binding proteins: stimulatory and inhibitory factors secreted by human prostatic adenocarcinoma cells. Growth Factors 4(3): 231-237

Martin, A.A.; Tomas, F.M.; Owens, P.C.; Knowles, S.E.; Ballard, F.J.; Read, L.C. 1991: IGF-i and its variant, des-(1-3)IGF-I, enhance growth in rats with reduced renal mass. American Journal of Physiology 261(4 Part 2): F626-F633

Lemmey, A.B.; Martin, A.A.; Read, L.C.; Tomas, F.M.; Owens, P.C.; Ballard, F.J. 1991: IGF-I and the truncated analogue des-(1-3)IGF-I enhance growth in rats after gut resection. American Journal of Physiology 260(2 Pt 1): E213-E219

Jennische, E.; Matejka, G.L. 1992: IGF-i binding and IGF-i expression in regenerating muscle of normal and hypophysectomized rats. Acta Physiologica Scandinavica 146(1): 79-86

Hansson, H.A.; Jennische, E.; Skottner, A. 1987: IGF-i expression in blood vessels varies with vascular load. Acta Physiologica Scandinavica 129(2): 165-169

Andersson, G.; Jennische, E. 1988: IGF-i immunoreactivity is expressed by regenerating renal tubular cells after ischaemic injury in the rat. Acta Physiologica Scandinavica 132(4): 453-457

Damante, G.; Cox, F.; Rapoport, B. 1988: IGF-i increases c-fos expression in FRTL5 rat thyroid cells by activating the c-fos promoter. Biochemical and Biophysical Research Communications 151(3): 1194-1199

Bondy, C.; Chin, E. 1991: IGF-i mRNA localization in trigeminal and sympathetic nerve target zones during rat embryonic development. Advances in Experimental Medicine and Biology 293: 431-437

Bilan, P.J.; Ramlal, T.; Klip, A. 1991: IGF-i mediated recruitment of glucose transporters from intracellular membranes to plasma membranes in L6 muscle cells. Advances in Experimental Medicine and Biology 293: 273-288

Wong, G.L.; Kotliar, D.; Schlaeger, D.; Brandes, S.J. 1990: IGF-i production by mouse osteoblasts. Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research 5(2): 133-140

Trouten-Radford, L.; Zhao, X.; McBride, B.W. 1991: IGF-i receptors in embryonic skeletal muscle of three strains of chickens selected for differences in growth capacity. Domestic Animal Endocrinology 8(1): 129-137

Waldbillig, R.J.; Fletcher, R.T.; Somers, R.L.; Chader, G.J. 1988: IGF-i receptors in the bovine neural retina: structure, kinase activity and comparison with retinal insulin receptors. Experimental Eye Research 47(4): 587-607

Rich, C.B.; Ewton, D.Z.; Martin, B.M.; Florini, J.R.; Bashir, M.; Rosenbloom, J.; Foster, J.A. 1992: IGF-i regulation of elastogenesis: comparison of aortic and lung cells. American Journal of Physiology 263(2 Part 1): L276-L282

Noguchi, A.; Nelson, T. 1991: IGF-I stimulates tropoelastin synthesis in neonatal rat pulmonary fibroblasts. Pediatric Research 30(3): 248-251

Serio, M.; Forti, G. 1989: IGF-I, IGF-Ii and gonadal function. Journal of Endocrinological Investigation 12(8 Suppl 3: 97-99

Jacob, V.; Le Carpentier, J.E.; Salzano, S.; Naylor, V.; Wild, G.; Brown, C.B.; el Nahas, A.M. 1990: IGF-I, a marker of undernutrition in hemodialysis patients. American Journal of Clinical Nutrition 52(1): 39-44

Dohm, G.L.; Elton, C.W.; Raju, M.S.; Mooney, N.D.; DiMarchi, R.; Pories, W.J.; Flickinger, E.G.; Atkinson, S.M.; Caro, J.F. 1990: IGF-I--stimulated glucose transport in human skeletal muscle and IGF-i resistance in obesity and NIDDM. Diabetes 39(9): 1028-1032

Sinha, M.K.; Buchanan, C.; Raineri-Maldonado, C.; Khazanie, P.; Atkinson, S.; DiMarchi, R.; Caro, J.F. 1990: IGF-Ii receptors and IGF-II-stimulated glucose transport in human fat cells. American Journal of Physiology 258(3 Part 1): E534-E542

Suzuki, T.; Iwafuchi, M.; Yanaihara, C.; Hatanaka, H.; Tao, Z.; Yanaihara, N.; Tanaka, H.; Nishikawa, K. 1989: IGF-II-like immunoreactivity in human tissues, neuroendocrine tumors, and PC12 cells. Diabetes Research and Clinical Practice 7(Suppl 1): S21-S27

Jackson, S.; Hodgkinson, S.; Estivariz, F.E.; Lowry, P.J. 1991: IGF1 and 2 in two models of adrenal growth. Journal of Steroid Biochemistry and Molecular Biology 40(1-3): 399-404

Liu, L.; Brinkman, A.; Blat, C.; Harel, L. 1991: IGFBP-1, an insulin like growth factor binding protein, is a cell growth inhibitor. Biochemical and Biophysical Research Communications 174(2): 673-679

Hall, K.; Brismar, K.; Grissom, F.; Lindgren, B.; Póvoa, G. 1991: IGFBP-1. Production and control mechanisms. Acta Endocrinologica 124(Suppl 2): 48-54

Shao, Z.M.; Sheikh, M.S.; Ordonez, J.V.; Feng, P.; Kute, T.; Chen, J.C.; Aisner, S.; Schnaper, L.; LeRoith, D.; Roberts, C.T. 1992: IGFBP-3 gene expression and estrogen receptor status in human breast carcinoma. Cancer Research 52(18): 5100-5103

Froesch, E.R.; Zapf, J. 1985: IGFs/somatomedins: physiological and physiopathological significance. Journees Annuelles de Diabetologie de l'Hotel-Dieu 1985: 101-111

Froesch, E.R.; Zapf, J. 1985: IGFs/somatomedins: significance for growth. Progress in Clinical and Biological Research 200: 75-89

Ferrante, A.; Beard, L.J.; Feldman, R.G. 1990: IgG subclass distribution of antibodies to bacterial and viral antigens. Pediatric Infectious Disease Journal 9(8 Suppl): S16-S24

Wasserman, R.L. 1988: IGG subclass determinations. Pediatric Infectious Disease Journal 7(4): 303-304

Schalch, L.; Rordorf-Adam, C.; Dasch, J.R.; Jungi, T.W. 1991: IGG-stimulated and LPS-stimulated monocytes elaborate transforming growth factor type beta (TGF-beta) in active form. Biochemical and Biophysical Research Communications 174(2): 885-891

De Benedictis, G.; Rose, G.; De Lange, G.G.; Brancati, C. 1988: IGHG1 phenotypes in three population samples from Italy (Albanians, Calabrians, northern Italians): a critical revision. Gene Geography: a Computerized Bulletin on Human Gene Frequencies 2(2-3): 129-132

Cuisinier, A.M.; Fumoux, F.; Fougereau, M.; Tonnelle, C. 1992: IGM kappa/lambda EBV human B cell clone: an early step of differentiation of fetal B cells or a distinct B lineage?. Molecular Immunology 29(11): 1363-1373

Yap, H.K.; Murugasu, B.; Saw, A.H.; Chiang, G.S. 1988: IGM nephropathy in childhood--is it a distinct entity?. Journal of the Singapore Paediatric Society 30(3-4): 145-149

Schulze-Lohoff, E.; Krapf, F.; Bleil, L.; Burmester, G.R.; Kölble, K.; Nüsslein, H.G.; Rödl, W.; Kalden, J.R. 1989: IGM-containing immune complexes and antiphospholipid antibodies in patients with Sneddon's syndrome. Rheumatology International 9(1): 43-48

Gomeni, C.; Gomeni, R. 1978: IGPHARM: interactive graphic package for pharmacokinetic analysis. Computers and Biomedical Research An International Journal 11(4): 345-361

DiPaolo, V. 1977: IHC predicts 20% growth during next five years. Modern Healthcare 7(10): 38-40

Babin, V.P.; Stepanova, E.G.; Malyutina, S.K. 1991: IHD in Chukotka residents: concentration of thyrotropin, thyroxin, triiodothyronine in blood serum. Arctic medical research Suppl: 430

Malyutina, S.K.; Ryabikov, A.N.; Astakhova, T.I.; Serova, N.V.; Nikitin YuP 1991: IHD in male population of Novosibirsk and Chukotka. Arctic Medical Research Suppl: 429

Welty, T.K. 1990: IHF proposes hepatitis a vaccine immunogenicity and efficacy trials. South Dakota Nurse 32(4): 21

Peacock, S.; Weissbach, H. 1985: IHF stimulation of lambda cIi gene expression is inhibited by the E. coli NusA protein. Biochemical and Biophysical Research Communications 127(3): 1026-1031

Anonymous 1989: IHIC alphabetical variant list. International Hemoglobin Information Center. Hemoglobin 13(3): 299-323

Heyrman, H. 1989: The Catastrophic Protection Act: boon or bane?. Home Healthcare Nurse 7(2): 9-11

Mosca, A.; Paleari, R.; Russo, V.; Rosti, E.; Nano, R.; Boicelli, A.; Villa, S.; Zanella, A. 1992: IHP entrapment into human erythrocytes: comparison between hypotonic dialysis and DMSO osmotic pulse. Advances in Experimental Medicine and Biology 326: 19-26

Kitamura, E.; Fujimori, M. 1977: IHSS and anesthesia. Masui. Japanese Journal of Anesthesiology 26(13): 1632-1639

Turakhia, D.P. 1990: IHSS--an insight into various findings. Journal of the Association of Physicians of India 38(6): 450-452

Ferreira, S.H.; Nakamura, M. 1979: Ii - Prostaglandin hyperalgesia: the peripheral analgesic activity of morphine, enkephalins and opioid antagonists. Prostaglandins 18(2): 191-200

Ribet, A. 1992: Chronic pancreatitis: diagnosis and medical treatment. Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 82(4): 258-259

Muñoz, E.R.; Barnett, B.M. 1977: II--IIi translocations induced by diethyl sulfate in mature sperm of Drosophila melanogaster. Mutation Research 45(3): 355-357

Ishida, N.; Nikaido, T.; Kondo, S.; Takeda, S.; Shimizu, A.; Honjo, T. 1985: II-2 receptor genes. Nihon Rinsho. Japanese Journal of Clinical Medicine 43(6): 1267-1275

Bouma, C.L.; Meadow, N.D.; Stover, E.W.; Roseman, S. 1987: II-BGlc, a glucose receptor of the bacterial phosphotransferase system: molecular cloning of ptsG and purification of the receptor from an overproducing strain of Escherichia coli. Proceedings of the National Academy of Sciences of the United States of America 84(4): 930-934

Wiener, S.L.; Nathanson, M. 1977: II-frequent errors in doing a physical. Medical Times 105(12): 79-82

Cameron, P.M.; Kline, S.; Korenblum, M.; Seltzer, A.; Small, F. 1978: II. A method of reporting formulation. Canadian Psychiatric Association Journal 23(1): 43-50

Kline, J.; Shrout, P.E.; Stein, Z.A.; Susser, M.; Weiss, M. 1978: II. An epidemiological study of the role of gravidity in spontaneous abortion. Early Human Development 1(4): 345-356

Valdés, M. 1976: II. Anatomopathological study on the aortas of chickens fed with eggs (arteriosclerosis) and their comparison with the normal chickens. Revista Espanola de Cardiologia 29(5): 377-384

Als, H. 1978: II. Assessing an assessment: conceptual considerations, methodological issues, and a perspective on the future of the Neonatal Behavioral Assessment Scale. Monographs of the Society for Research in Child Development 43(5-6): 14-28

Cotes, J.E. 1975: II. Assessment of disablement due to impaired respiratory function. Bulletin de Physio-Pathologie Respiratoire 11(6): 210p-217p

Todd, M.C. 1975: II. Brown University Alcoholism Conference: Keynote address: How future physicians must see the alcoholic. R.I. Medical Journal 58(9): 389-90 401

Wallgren, C.G.; Kretzschmar, G.; Zetterqvist, P. 1975: II. Cardiac output studies in infants and children undergoing right heart catheterization. Acta Paediatrica Scandinavica. Suppl 254: 7-11

Cutillo, S. 1979: II. Chronic hemolytic anemia caused by erythrocytic deficiency of glucose-6-phosphate dehydrogenase (G6PD). La Pediatria 87(4): V-VI

Long, R.S. 1975: II. Confidentiality of patient medical information. Transactions and Studies of the College of Physicians of Philadelphia 42(4): 382-385

Charro Salgado, A.L.; López Macia, A.; Bagazgoitia, J.; Oriol Bosch, A.; Fernández-Cruz, A. 1976: II. Dexamethasone, metopirone and ACTH tests in the diagnosis of diseases of the hypothalamo-hypopyseal adrenal axis. Revista Clinica Espanola 141(3): 227-230

Dawson, M.H. 1979: II. Disease and social change. Smallpox in Kenya, 1880-1920. Social Science and Medicine. Medical Anthropology 13b(4): 245-250

Luzzio, A.J.; McRoberts, M.J.; Euliss, N.H. 1979: Quantitative estimation of leishmanial antibody titers by enzyme-linked immunosorbent assay. Journal of Infectious Diseases 140(3): 370-377

Coleridge, H.M.; Coleridge, J.C.; Banzett, R.B. 1978: II. Effect of CO2 on afferent vagal endings in the canine lung. Respiration Physiology 34(1): 135-151

Karmali, R.A.; Chao, C.C.; Basu, A.; Modak, M. 1989: II. Effect of n-3 and n-6 fatty acids on mammary H-ras expression and PGE2 levels in DMBA-treated rats. Anticancer Research 9(4): 1169-1174

Mosskov, J.I.; Ettema, J.H. 1977: II. Extra-auditory effects in short-term exposure to aircraft and traffic noise. International Archives of Occupational and Environmental Health 40(3): 165-173

Dabancens, A.; Fuensalida, S.; González, O. 1976: II. Histology of the ovary in women treated with 3.75 mg of conjugated estrogens during 20 days. Revista Chilena de Obstetricia y Ginecologia 41(6): 337-340

Murray, D.C.; Davidoff, L.; Harrington, L.G. 1975: II. in vivo self-control training. Psychological Reports 37(1): 249-258

Rosenfeldt, F.L.; Watson, D.A. 1979: II. Interference with local myocardial cooling by heat gain during aortic cross-clamping. Annals of Thoracic Surgery 27(1): 13-16

Ming, S.C. 1976: II. Malignant potential of gastric polyps. Gastrointestinal Radiology 1(2): 121-125

McLean, R.A.; Cochrane, N.E.; Mattison, E.T. 1979: II. Maternal deaths due to rupture of uterus. New York State Journal of Medicine 79(1): 46-49

Louwagie, A.C. 1977: II. Mechanism of increased colony formation of CFU-S and CFU-C after in vivo PHA administration in mice. Haematologia 11(3-4): 321-330

Venikova, M.S. 1985: II. Morphologic criteria of synovitis in rheumatoid arthritis and correlation with synovitis in systemic lupus erythematosus and systemic scleroderma. Revmatologiia 4: 31-36

Siegers, C.P. 1978: II. Mushroom poisoning. Zfa. Zeitschrift für Allgemeinmedizin 54(24): 1190-1195

Tohá, J.; Soto, M.A.; Pieber, M. 1979: II. on the construction of a phylogenetic tree. Zeitschrift für Naturforschung. Section C Biosciences 34(12): 1269-1271

Trujillo Rodríguez, F.; Rodríguez Portillo, M.; Aznar Reig, A. 1979: II. Oncotic pressure of plasma: total proteinemia. Albumin/globulin quotients. Revista Clinica Espanola 155(2): 89-91

Vogel, L.C.; Sjoerdsma, A.C.; Swinkels, W.J.; W'Oigo, H.O. 1979: II. Operational experiments in the outpatient department (1970-1972). Tropical and Geographical Medicine 31(3): Suppl. 23-31

Wente, M.A. 1977: II. Particulate matter levels in large-volume injections: USP XIX method. Bulletin of the Parenteral Drug Association 31(4): 165-169

Palm, E. 1975: II. Pathophysiological aspects on the surgery of iris and the ciliary body. Advances in Ophthalmology 30: 55-73

Lévy, V.G.; Nusinovici, V.; Rosner, D.; Darnis, F. 1979: II. Prevention of migraine using chenodeoxycholic acid (C.D.C.A.). Medecine and Chirurgie Digestives 8(3): 248-249

López Aydillo, N.R.; Ramírez Gómez, C. 1978: II. Probable etiology of alopecia in the Spanish lathyric patients. Results of study of toxins in fungi that develop in the external surface of the seeds of Lathyrus sativus. Archivos de Neurobiologia 41(6): 461-486

Filatov, V.V.; Osanov, D.P. 1977: II. Role of diffusion in the process of radioactive substance transport through the skin. Biofizika 22(1): 96-101

Rapp, G.F. 1978: II. Safety suggestions for trampoline use. Pediatric Annals 7(10): 730-731

de Micheli, A. 1977: II. Science of the romantic era in the national and pontifical university of Mexico. La Prensa Medica Mexicana 42(7-8): 274-279

Camarda, A.J.; Deschamps, C.; Forest, D. 1989: II. Stylohyoid chain ossification: a discussion of etiology. Oral Surgery Oral Medicine and Oral Pathology 67(5): 515-520

Held, A.J. 1978: II. Surgery of the masticatory apparatus (findings selected from the 1977-1978 literature). Schweizerische Monatsschrift für Zahnheilkunde 88(9): 1020-1033

Berg, K.R. 1975: II. the Hartford ghetto, 1973: pitfalls and problems of community psychology. Hospital and Community Psychiatry 26(4): 225-227

Ranney, B.; Stanage, W.F. 1975: II. The advantages of local anesthesia for cesarean section (prenatal, neonatal, and developmental comparisons). South Dakota Journal of Medicine 28(2): 23-31

Berg, B.H. 1975: II. the influence of 17-beta-oestradiol on aminoacyl-tRNA synthetases from mouse uterus and mouse liver. Biochimica et Biophysica Acta 395(2): 173-178

Guélin, A. 1976: II. the process of spontaneous bacteriolysis in water and micropredator bacteria. Mikrobiyoloji Bulteni 10(1): 73-75

Mandache, F.; Prodescu, V.; Constantinescu, S.; Kover, G.; Ghergut, A.; Popescu, M.; Dimitriu, C.; Curea, I. 1975: II. Treatment of duodenal ulcer by chemical sclerosis of the gastric mucosa. Preliminary results. Chirurgie; Memoires de l'Academie de Chirurgie 101(2): 139-151

Fourrier, A.; Becquet, R.; Vernes, A.; Mouton, Y.; Afchain, D.; Libersa, C. 1976: II. Tryopanosomiasis, onchercercosis, tropical diseases that travel. Lille Medical: Journal de la Faculte de Medecine et de Pharmacie de l'Universite de Lille 21(5): 457-459

Mandache, E.; Moraru, I.; Sjöquist, J.; Gheţie, V. 1978: II. Ultrastructural differences in attachment patterns of indicator cells to target cells in the rosette-forming process. Journal of Immunological Methods 22(1-2): 91-97

Coujard, M.F. 1978: II. Ultrastructure of rat superior cervical ganglion cells in organ culture and grafts. Zeitschrift für Mikroskopisch-Anatomische Forschung 92(4): 655-674

Kiseleva, V.I.; Turchinskiĭ, M.F.; Poverennyĭ, A.M. 1991: II. use of antibodies to DNA modified by trans-diaminodichloroplatinum, for identification of specific DNA sequences. Molekuliarnaia Biologiia 25(2): 508-514

Newmark, H. 1975: II. Views of the pharmaceutical industry on the regulations. Bulletin of the Parenteral Drug Association 29(5): 218-221

Contreras, G.; Grado, C.; Suárez, M. 1977: II. Viral vaccines. Vaccines of limited use and vaccines in development. Revista Chilena de Pediatria 48(2): 98-102

Taranger, J. 1976: II. evaluation of biological maturation by means of maturity criteria. Acta Paediatrica Scandinavica. Suppl 258: 77-82

Trapeznikov, N.N.; Amiraslanov, A.T. 1991: IIB osteosarcoma. Current management and survival statistics in the USSR. Clinical Orthopaedics and Related Research 270: 107-112

Petrilli, S.; Penna, V.; Lopes, A.; Figueiredo, M.T.; Gentil, F.C. 1991: IIB osteosarcoma. Current management, local control, and survival statistics--São Paulo, Brazil. Clinical Orthopaedics and Related Research 270: 60-66

Veth, R.P. 1991: IIB osteosarcoma. Current management, local control, and survival statistics--The Netherlands. Clinical Orthopaedics and Related Research 270: 67-71

Marsden, F.W.; Stephens, F.O.; McCarthy, S.W.; Ferrari, A.M. 1991: IIB osteosarcoma. Current management, local control, and survival statistics--the Australian experience. Clinical Orthopaedics and Related Research 270: 113-119

Kyrle, P.A.; Niessner, H.; Dent, J.; Panzer, S.; Brenner, B.; Zimmerman, T.S.; Lechner, K. 1988: IIB von Willebrand's disease: pathogenetic and therapeutic studies. British Journal of Haematology 69(1): 55-59

Boda, Z.; Hársfalvi, J.; Rák, K. 1985: IIB-type Willebrand disease (a case of increased ristomycin-induced aggregation). Orvosi Hetilap 126(32): 1957-1960

Ferreira, S.H.; Nakamura, M. 1979: IIi - Prostaglandin hyperalgesia: relevance of the peripheral effect for the analgesic action of opioid-antagonists. Prostaglandins 18(2): 201-208

Láng, I.; Nékám, K.; Deák, G.; Müzes, G.; Gonzales-Cabello, R.; Gergely, P.; Csomós, G.; Fehér, J. 1990: Immunomodulatory and hepatoprotective effects of in vivo treatment with free radical scavengers. Italian Journal of Gastroenterology 22(5): 283-287

Meister, F.; Davies, E.E.; Engel, H.L. 1977: III-fitting dentures: surgery for hyperplastic tissue. Dental Survey 53(12): 38-42

McLean, R.A.; Cochrane, N.E.; Mattison, E.T. 1979: III. Abortion and mortality study. Twenty-year study in new York State exclusive of new York City. New York State Journal of Medicine 79(1): 49-52

Sullivan, K.A.; Flaherty, L. 1979: The Qa-2 antigen on lymphocyte subpopulations. Mixed lymphocyte culture and cell-mediated lympholysis. Journal of Immunology 123(6): 2920-2924

Bosma, W.G. 1975: III. Brown University Alcoholism Conference: On undergraduate education: alcoholism in a medical school. R.I. Medical Journal 58(9): 391

Schumpelik, V.; Hempel, K.; Schreiber, H.W. 1978: III. Continued education in surgery. A. Prospective studies, methods for determination of therapy results. Topics on and results of prospective studies in surgery. Langenbecks Archiv für Chirurgie 347: 449-456

Porter, M.C. 1977: III. Detection of small particulates on membrane filters. Bulletin of the Parenteral Drug Association 31(4): 170-172

Dabancens, A.; Fuensalida, S.; González, O. 1976: III. Effect of conjugated estrogens on the endometrium. Revista Chilena de Obstetricia y Ginecologia 41(6): 341-344

Fuchs, U. 1979: Pathology of micro and macroangiopathies. Zeitschrift für Arztliche Fortbildung 73(10): 463-467

Wallgren, C.G. 1975: III. Evaluation of the forward triangle area in dye curves from infants and children studied by earpiece densitometry. Acta Paediatrica Scandinavica. Suppl 254: 12-14

Kreye, O. 1975: III. Expert testimony problems in orthopedics. A. General information expert testimony. Malpractice lesions. Beitrage Zur Orthopadie und Traumatologie 22(2): 110-112

Mosskov, J.I.; Ettema, J.H. 1977: III. Extra-auditory effects in short-term exposure to noise from a textile factory. International Archives of Occupational and Environmental Health 40(3): 174-176

Kanaan, S.B. 1991: Financing policy for mental health services. Health Affairs 10(2): 207-211

Malik, C.P.; Vermani, S.; Bhatia, D.S. 1976: III. Histochemical characteristics of suspensor during embryo development in Brassica campestris Linn. var., Sarson. Acta Histochemica 57(2): 178-182

Feierman, S. 1979: III. History of pluralistic medical systems. Change in African Therapeutic systems. Social Science and Medicine. Medical Anthropology 13b (4): 277-284

Entmacher, P.S. 1975: III. Insurance safeguards and the consumer's right to know. Transactions and Studies of the College of Physicians of Philadelphia 42(4): 385-388

Barraquer, J. 1975: III. Iridectomy and iridotomy. Advances in ophthalmology = Fortschritte der Augenheilkunde = Progres en ophtalmologie 30: 75-130

Kamada, N.; Oguma, N. 1977: III. Leukemogenic factors and chromosome aberrations. Japanese Journal of Clinical Hematology 18(6): 765-770

Rosenfeldt, F.L.; Watson, D.A. 1979: III. Local cardiac hypothermia: experimental comparison of Shumway's technique and perfusion cooling. Annals of Thoracic Surgery 27(1): 17-23

Gerblich, A.A.; Kleinerman, J. 1977: Blunt chest trauma and the lung. American Review of Respiratory Disease 115(3): 369-370

Torrado Da Silva, M.; Cramer, B.; Manzano, J.; Palacio-Espasa, F. 1979: III. Preventive programs in a guidance service for preschool children: the preventive role of a therapeutic child nursery. Acta Paedopsychiatrica 44(2): 101-109

van Luijk, J.N. 1979: III. Profile, expectation and satisfaction of outpatients (1970-1972). Tropical and Geographical Medicine 31(3): Suppl. 33-59

Klinkert, L.M.; Nijstad, J. 1976: III. Research on the effect of the educational campaign for healthy teeth. Nederlands Tijdschrift Voor Tandheelkunde 83(2): 69-78

Horowitz, F.D.; Sullivan, J.W.; Linn, P. 1978: III. Stability and instability in the newborn infant: the quest for elusive threads. Monographs of the Society for Research in Child Development 43(5-6): 29-45

Harnack, K.; Sönnichsen, N.; Werchan, D. 1976: III. Standard prescriptions. Dermatologische Monatschrift 162(6): 527-532

Goldstein, N.; Sewell, M. 1979: III. Tattoos in different cultures. Journal of Dermatologic Surgery and Oncology 5(11): 857-864

Berg, B.H. 1975: III. the RNA component of aminoacyl-tRNA synthetase complexes isolated from mouse liver. Absence of amino acid accepting activity. Biochimica et Biophysica Acta 414(2): 93-98

Valensi, P.L.; Palàt, M. 1975: III. the state of readaptation of patients with chronic lung diseases in Europe. Bulletin de Physio-Pathologie Respiratoire 11(6): 218p-221p

Argenziano Cutolo, A.; Skoff, G. 1988: III. Trace elements in cigarettes. Bollettino Chimico Farmaceutico 127(7-8): 180-181

Cole, J.C. 1975: III. Views of the filter manufacturers on the regulations. Bulletin of the Parenteral Drug Association 29(5): 222-226

Taranger, J.; Lichtenstein, H.; Svennberg-Redegren, I. 1976: III. dental development from birth to 16 years. Acta Paediatrica Scandinavica. Suppl 258: 83-97

Law, K.L.; Smith, D.F. 1987: III6NeuAcLc4Cer in human SW1116 colorectal carcinoma cells: a possible oncofetal antigen that is not dependent on Lewis gene expression. Archives of Biochemistry and Biophysics 258(2): 315-323

Meyerhoeffer, D.C.; Wettemann, R.P.; Coleman, S.W.; Wells, M.E. 1985: Reproductive criteria of beef bulls during and after exposure to increased ambient temperature. Journal of Animal Science 60(2): 352-357

Takada, Y.; Tsushimi, K.; Yamamoto, T. 1988: IIa type of early carcinoma of the ascending colon, report of a case, and studies on the series of twenty-three cases of early colorectal carcinomas. Nihon Geka Hokan. Archiv für Japanische Chirurgie 57(1): 115-120

Dubois, M.F.; Bensaude, O.; Morange, M. 1991: IIa/IIo conversion of RNA polymerase Ii during heat shock. Comptes Rendus de l'Academie des Sciences. Serie Iii Sciences de la Vie 313(3): 165-170

Houtzager, H.L.; van Diemerbroeck, I.J. 1976: IJsbrand van Diemerbroeck (1609-1674). Nederlands Tijdschrift Voor Geneeskunde 120(8): 340-346

Clay, J.R. 1990: IK inactivation in squid axons is shifted along the voltage axis by changes in the intracellular pH. Biophysical Journal 58(3): 797-801

Gieloff, B.; Arps, J.; Kanth, L. 1988: IK-implants and their prosthetic maintenance. Zwr 97(6): 514-520

Kryzhanov, M.A.; Tupitsin, N.N.; Savel'eva, E.V.; Shishkin, I.V.; Drozdova, T.S. 1985: IKO-GM-1 monoclonal antibodies in the diagnosis of acute nonlymphoblastic leukemias. Voprosy Onkologii 31(7): 79-83

Takacs, L.; Berzofsky, J.A.; York-Jolley, J.; Akahoshi, T.; Blasi, E.; Durum, S.K. 1987: IL 1 induction by murine T cell clones: detection of an IL 1-inducing lymphokine. Journal of Immunology 138(7): 2124-2131

Jyonouchi, H.; Voss, R.M.; Good, R.A. 1987: IL 1-like activities present in murine amniotic fluid. a significantly larger amount of IL 1 beta-like activity is present in the amniotic fluid of autoimmune NZB mice. Journal of Immunology 138(10): 3300-3307

Gerrard, T.L.; Volkman, D.J. 1985: IL 1-like activity in antigen-presenting human B cell lines. Journal of Immunology 135(5): 3217-3223

Taylor, D.S.; Kern, J.A.; Nowell, P.C. 1986: IL 2 alone is mitogenic only for Tac-positive lymphocytes in human peripheral blood. Journal of Immunology 136(5): 1620-1624

Habu, S. 1986: IL 2 receptor expression on differentiating lymphocytes in the murine thymocyte. Immunological Reviews 92: 67-80

Wakasugi, H.; Bertoglio, J.; Tursz, T.; Fradelizi, D. 1985: IL 2 receptor induction on human T lymphocytes: role for IL 2 and monocytes. Journal of Immunology 135(1): 321-327

Ishihara, T.; Takahara, S.; Fathman, C.G. 1986: IL 2 restores memory B cell activation by antigen-specific T cell clone variants. Journal of Immunology 136(1): 39-43

Barton, B.E.; Mayer, R. 1990: IL 3 and IL 6 do not induce bone resorption in vitro. Cytokine 2(3): 217-220

Lévy, Y.; Brouet, J.C. 1991: IL 6 and lymphoproliferative diseases. Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 185(5): 262-267

Johnsson, J. 1992: IL hospital agrees to secondary market disclosure program. Hospitals 66(16): 66

Anonymous 1985: IL hospital reduces ER liability risks. Hospitals 59(18): 66

Shahoda, T. 1987: IL hospitals' liability costs increase 103%. Hospitals 61(1): 28

Traska, M.R. 1986: IL institutions use "gambling" to raise funds. Hospitals 60(21): 58

Muñoz, E.; Beutner, U.; Zubiaga, A.; Huber, B.T. 1990: IL-1 activates two separate signal transduction pathways in T helper type Ii cells. Journal of Immunology 144(3): 964-969

Cooper, K.D.; Hammerberg, C.; Baadsgaard, O.; Elder, J.T.; Chan, L.S.; Sauder, D.N.; Voorhees, J.J.; Fisher, G. 1990: IL-1 activity is reduced in psoriatic skin. Decreased IL-1 alpha and increased nonfunctional IL-1 beta. Journal of Immunology 144(12): 4593-4603

Nagai, S. 1987: IL-1 activity released from culture supernatants of alveolar macrophages in patients with sarcoidosis. Nihon Kyobu Shikkan Gakkai Zasshi 25(10): 1089-1095

Nakazato, Y.; Sedor, J.R. 1992: IL-1 alpha increases arachidonyl-CoA: lysophospholipid acyltransferase activity and stimulates [3H]arachidonate incorporation into phospholipids in rat mesangial cells. Life Sciences 50(26): 2075-2082

Bristol, L.A.; Ruscetti, F.W.; Brody, D.T.; Durum, S.K. 1990: IL-1 alpha induces expression of active transforming growth factor-beta in nonproliferating T cells via a post-transcriptional mechanism. Journal of Immunology 145(12): 4108-4114

Akahane, K.; Cohen, R.B.; Bickel, M.; Pluznik, D.H. 1991: IL-1 alpha induces granulocyte-macrophage colony-stimulating factor gene expression in murine B lymphocyte cell lines via mRNA stabilization. Journal of Immunology 146(12): 4190-4196

Dawson, J.; Edwards, J.C.; Sedgwick, A.D.; Lees, P. 1991: IL-1 alpha inhibits lymphocyte migration into a site of chronic inflammation. Immunology Letters 30(3): 319-323

Cerdan, C.; Martin, Y.; Brailly, H.; Courcoul, M.; Flavetta, S.; Costello, R.; Mawas, C.; Birg, F.; Olive, D. 1991: IL-1 alpha is produced by T lymphocytes activated via the CD2 plus CD28 pathways. Journal of Immunology 146(2): 560-564

Schröder, J.M.; Sticherling, M.; Henneicke, H.H.; Preissner, W.C.; Christophers, E. 1990: IL-1 alpha or tumor necrosis factor-alpha stimulate release of three NAP-1/IL-8-related neutrophil chemotactic proteins in human dermal fibroblasts. Journal of Immunology 144(6): 2223-2232

Yard, B.A.; Daha, M.R.; Kooymans-Couthino, M.; Bruijn, J.A.; Paape, M.E.; Schrama, E.; van Es, L.A.; van der Woude, F.J. 1992: IL-1 alpha stimulated TNF alpha production by cultured human proximal tubular epithelial cells. Kidney International 42(2): 383-389

Martin, S.; Maruta, K.; Burkart, V.; Gillis, S.; Kolb, H. 1988: IL-1 and IFN-gamma increase vascular permeability. Immunology 64(2): 301-305

Nagai, S.; Aung, H.; Takeuchi, M.; Kusume, K.; Izumi, T. 1991: IL-1 and IL-1 inhibitory activity in the culture supernatants of alveolar macrophages from patients with interstitial lung diseases. Chest 99(3): 674-680

Lacey, D.L.; Erdmann, J.M. 1990: IL-1 and IL-4 modulate IL-1 receptor expression in a murine T cell line. Journal of Immunology 145(12): 4145-4153

Lin, B.F.; Ku, N.O.; Zahedi, K.; Whitehead, A.S.; Mortensen, R.F. 1990: IL-1 and IL-6 mediate increased production and synthesis by hepatocytes of acute-phase reactant mouse serum amyloid P-component (SAP). Inflammation 14(3): 297-313

Erroi, A.; Sironi, M.; Chiaffarino, F.; Chen, Z.G.; Mengozzi, M.; Mantovani, A. 1989: IL-1 and IL-6 release by tumor-associated macrophages from human ovarian carcinoma. International Journal of Cancer 44(5): 795-801

Natsuaki, M.; Higasa, M.; Sagami, S.; Shinka, S. 1989: IL-1 and PGE2 productions by the regional lymph node cells from DNFB-sensitized mice. Journal of Dermatology 16(2): 111-115

Bird, T.A.; Saklatvala, J. 1989: IL-1 and TNF transmodulate epidermal growth factor receptors by a protein kinase C-independent mechanism. Journal of Immunology 142(1): 126-133

Kasahara, T.; Mukaida, N.; Yamashita, K.; Yagisawa, H.; Akahoshi, T.; Matsushima, K. 1991: IL-1 and TNF-alpha induction of IL-8 and monocyte chemotactic and activating factor (MCAF) mRNA expression in a human astrocytoma cell line. Immunology 74(1): 60-67

Curtis, B.M.; Widmer, M.B.; deRoos, P.; Qwarnstrom, E.E. 1990: IL-1 and its receptor are translocated to the nucleus. Journal of Immunology 144(4): 1295-1303

Elias, J.A.; Lentz, V. 1990: IL-1 and tumor necrosis factor synergistically stimulate fibroblast IL-6 production and stabilize IL-6 messenger RNA. Journal of Immunology 145(1): 161-166

Katz, Y.; Strunk, R.C. 1989: IL-1 and tumor necrosis factor. Similarities and differences in stimulation of expression of alternative pathway of complement and IFN-beta 2/IL-6 genes in human fibroblasts. Journal of Immunology 142(11): 3862-3867

Mizuochi, T.; McKean, D.J.; Singer, A. 1988: IL-1 as a co-factor for lymphokine-secreting CD8+ murine T cells. Journal of Immunology 141(5): 1571-1575

Mertz, P.M.; Sauder, D.L.; Davis, S.C.; Kilian, P.L.; Herron, A.J.; Eaglstein, W.H. 1991: IL-1 as a potent inducer of wound re-epithelization. Progress in Clinical and Biological Research 365: 473-480

Durum, S.K.; Brody, D.T.; Tartakovsky, B. 1987: IL-1 as a self-serving principle in T-cell clones. Annales de l'Institut Pasteur. Immunology 138(3): 469-472

Reed, S.G.; Pihl, D.L.; Conlon, P.J.; Grabstein, K.H. 1989: IL-1 as adjuvant. Role of T cells in the augmentation of specific antibody production by recombinant human IL-1 alpha. Journal of Immunology 142(9): 3129-3133

Kim, K.S.; Le, J. 1992: IL-1 beta and Escherichia coli. Science 258(5088): 1562-1563

Xing, Z.; Jordana, M.; Gauldie, J. 1992: IL-1 beta and IL-6 gene expression in alveolar macrophages: modulation by extracellular matrices. American Journal of Physiology 262(5 Part 1): L600-L605

Milam, S.B.; Magnuson, V.L.; Steffensen, B.; Chen, D.; Klebe, R.J. 1991: IL-1 beta and prostaglandins regulate integrin mRNA expression. Journal of Cellular Physiology 149(2): 173-183

Beuscher, H.U.; Günther, C.; Röllinghoff, M. 1990: IL-1 beta is secreted by activated murine macrophages as biologically inactive precursor. Journal of Immunology 144(6): 2179-2183

Perregaux, D.; Barberia, J.; Lanzetti, A.J.; Geoghegan, K.F.; Carty, T.J.; Gabel, C.A. 1992: IL-1 beta maturation: evidence that mature cytokine formation can be induced specifically by nigericin. Journal of Immunology 149(4): 1294-1303

Wilson, C.A.; Jacobs, C.; Baker, P.; Baskin, D.G.; Dower, S.; Lernmark, A.; Toivola, B.; Vertrees, S.; Wilson, D. 1990: IL-1 beta modulation of spontaneous autoimmune diabetes and thyroiditis in the BB rat. Journal of Immunology 144(10): 3784-3788

Arend, W.P.; Gordon, D.F.; Wood, W.M.; Janson, R.W.; Joslin, F.G.; Jameel, S. 1989: IL-1 beta production in cultured human monocytes is regulated at multiple levels. Journal of Immunology 143(1): 118-126

Hernvann, A.; Aussel, C.; Cynober, L.; Moatti, N.; Ekindjian, O.G. 1992: IL-1 beta, a strong mediator for glucose uptake by rheumatoid and non-rheumatoid cultured human synoviocytes. Febs Letters 303(1): 77-80

Peracchia, F.; Ferrari, G.; Poggi, A.; Rotilio, D. 1991: IL-1 beta-induced expression of PDGF-AA isoform in rabbit articular chondrocytes is modulated by TGF-beta 1. Experimental Cell Research 193(1): 208-212

Maloff, B.L.; Shaw, J.E.; Di Meo, T.M. 1989: IL-1 dependent model of inflammation mediated by neutrophils. Journal of Pharmacological Methods 22(2): 133-140

Donnelly, R.P.; Fenton, M.J.; Kaufman, J.D.; Gerrard, T.L. 1991: IL-1 expression in human monocytes is transcriptionally and posttranscriptionally regulated by IL-4. Journal of Immunology 146(10): 3431-3436

Duncan, L.M.; Meegan, L.S.; Unanue, E.R. 1991: IL-1 gene expression in lymphoid tissues. Journal of Immunology 146(2): 565-571

Bomalaski, J.S.; Steiner, M.R.; Simon, P.L.; Clark, M.A. 1992: IL-1 increases phospholipase A2 activity, expression of phospholipase A2-activating protein, and release of linoleic acid from the murine T helper cell line EL-4. Journal of Immunology 148(1): 155-160

Ghezzi, P.; Dinarello, C.A. 1988: IL-1 induces IL-1. III. Specific inhibition of IL-1 production by IFN-gamma. Journal of Immunology 140(12): 4238-4244

Schindler, R.; Ghezzi, P.; Dinarello, C.A. 1990: IL-1 induces IL-1. IV. IFN-gamma suppresses IL-1 but not lipopolysaccharide-induced transcription of IL-1. Journal of Immunology 144(6): 2216-2222

Falk, W.; Männel, D.N.; Darjes, H.; Krammer, P.H. 1989: IL-1 induces high affinity IL-2 receptor expression of CD4-8- thymocytes. Journal of Immunology 143(2): 513-517

Bristol, L.A.; Smith, M.R.; Bhat, N.K.; Durum, S.K. 1991: IL-1 induces ornithine decarboxylase in normal T lymphocytes. Journal of Immunology 146(5): 1509-1515

Gallis, B.; Prickett, K.S.; Jackson, J.; Slack, J.; Schooley, K.; Sims, J.E.; Dower, S.K. 1989: IL-1 induces rapid phosphorylation of the IL-1 receptor. Journal of Immunology 143(10): 3235-3240

Loppnow, H.; Brade, H.; Dürrbaum, I.; Dinarello, C.A.; Kusumoto, S.; Rietschel, E.T.; Flad, H.D. 1989: IL-1 induction-capacity of defined lipopolysaccharide partial structures. Journal of Immunology 142(9): 3229-3238

Matsuzaki, N.; Samejima, Y.; Azuma, C.; Negoro, T.; Saji, F.; Tanizawa, O. 1987: IL-1 inhibitor in ascites fluids from ovarian cancer patients. Nihon Sanka Fujinka Gakkai Zasshi 39(12): 2197-2198

Dorshkind, K. 1988: IL-1 inhibits B cell differentiation in long term bone marrow cultures. Journal of Immunology 141(2): 531-538

Tartakovsky, B.; Finnegan, A.; Muegge, K.; Brody, D.T.; Kovacs, E.J.; Smith, M.R.; Berzofsky, J.A.; Young, H.A.; Durum, S.K. 1988: IL-1 is an autocrine growth factor for T cell clones. Journal of Immunology 141(11): 3863-3867

Shieh, J.H.; Peterson, R.H.; Moore, M.A. 1991: IL-1 modulation of cytokine receptors on bone marrow cells. in vitro and in vivo studies. Journal of Immunology 147(4): 1273-1278

Gothelf, Y.; Dinarello, C.A.; Yamin, M.; Sharon, N.; Milner, Y.; Gazit, E. 1989: IL-1 production by T6 (CD1a) positive cord blood mononuclear cells (Langerhan's cell precursors?). Lymphokine Research 8(4): 373-382

Szkaradkiewicz, A. 1991: IL-1 production by human monocytes in viral hepatitis type B. Journal of Hepatology 13(3): 381-382

Lafontaine, M.; Landry, D.; Blanc-Brunât, N.; Pelletier, M.; Montplaisir, S. 1991: IL-1 production by human thymic dendritic cells: studies on the interrelation with DC accessory function. Cellular Immunology 135(2): 431-444

Arend, W.P.; Smith, M.F.; Janson, R.W.; Joslin, F.G. 1991: IL-1 receptor antagonist and IL-1 beta production in human monocytes are regulated differently. Journal of Immunology 147(5): 1530-1536

Firestein, G.S.; Berger, A.E.; Tracey, D.E.; Chosay, J.G.; Chapman, D.L.; Paine, M.M.; Yu, C.; Zvaifler, N.J. 1992: IL-1 receptor antagonist protein production and gene expression in rheumatoid arthritis and osteoarthritis synovium. Journal of Immunology 149(3): 1054-1062

Bevan, S.; Raynes, J.G. 1991: IL-1 receptor antagonist regulation of acute phase protein synthesis in human hepatoma cells. Journal of Immunology 147(8): 2574-2578

Ghiara, P.; Scapigliati, G.; Censini, S.; Bartalini, M.; Bossù, P.; Armellini, D.; Nuti, S.; Volpini, G.; Dallai, R.; Boraschi, D. 1990: IL-1 receptor subtypes possess distinct binding properties for IL-1 alpha and IL-1 beta. Progress in Clinical and Biological Research 349: 271-284

Rosoff, P.M. 1990: IL-1 receptors: structure and signals. Seminars in Immunology 2(2): 129-137

Dularay, B.; Westacott, C.I.; Elson, C.J. 1992: IL-1 secreting cell assay and its application to cells from patients with rheumatoid arthritis. British Journal of Rheumatology 31(1): 19-24

Levin, D.; Gershon, H. 1988: IL-1 secretion and membrane IL-1 expression by neonatal spleen cells during soluble antigen presentation. Cellular Immunology 116(2): 382-391

Suttles, J.; Giri, J.G.; Mizel, S.B. 1990: IL-1 secretion by macrophages. Enhancement of IL-1 secretion and processing by calcium ionophores. Journal of Immunology 144(1): 175-182

Schmitt, E.; Beuscher, H.U.; Huels, C.; Monteyne, P.; van Brandwijk, R.; van Snick, J.; Ruede, E. 1991: IL-1 serves as a secondary signal for IL-9 expression. Journal of Immunology 147(11): 3848-3854

Muñoz Blanco, E. 1991: IL-1 signal transduction. Immunology Today 12(8): 287-288

Muñoz, E.; Zubiaga, A.M.; Sims, J.E.; Huber, B.T. 1991: IL-1 signal transduction pathways. I. two functional IL-1 receptors are expressed in T cells. Journal of Immunology 146(1): 136-143

Saklatvala, J.; Bird, T.A.; Kaur, P.; O'Neill, L.A. 1990: IL-1 signal transduction: evidence of activation of G protein and protein kinase. Progress in Clinical and Biological Research 349: 285-295

Didier, M.; Aussel, C.; Pelassy, C.; Fehlmann, M. 1988: IL-1 signaling for IL-2 production in T cells involves a rise in phosphatidylserine synthesis. Journal of Immunology 141(9): 3078-3080

Sironi, M.; Breviario, F.; Proserpio, P.; Biondi, A.; Vecchi, A.; Van Damme, J.; Dejana, E.; Mantovani, A. 1989: IL-1 stimulates IL-6 production in endothelial cells. Journal of Immunology 142(2): 549-553

Jimenez, J.J.; Huang, H.S. 1992: IL-1 synergizes with ARA-C in aborting the development of chloroleukemia while protecting from ARA-C-induced alopecia in the rat model. Cytokine 4(6): 551-554

Lazenby, A.W.; Roth, J.A.; Owen-Schaub, L.B.; Grimm, E.A. 1992: IL-1 synergy with IL-2 in the generation of lymphokine activated killer cells is mediated by TNF-alpha and beta (lymphotoxin). Cytokine 4(6): 479-487

Sica, A.; Matsushima, K.; Van Damme, J.; Wang, J.M.; Polentarutti, N.; Dejana, E.; Colotta, F.; Mantovani, A. 1990: IL-1 transcriptionally activates the neutrophil chemotactic factor/IL-8 gene in endothelial cells. Immunology 69(4): 548-553

Kitamura, T.; Takaku, F.; Miyajima, A. 1991: IL-1 up-regulates the expression of cytokine receptors on a factor-dependent human hemopoietic cell line, TF-1. International Immunology 3(6): 571-577

Rubio, N.; Torres, C. 1991: IL-1, IL-2 and IFN-gamma production by Theiler's virus-induced encephalomyelitic SJL/J mice. Immunology 74(2): 284-289

Galy, A.H.; Spits, H. 1991: IL-1, IL-4, and IFN-gamma differentially regulate cytokine production and cell surface molecule expression in cultured human thymic epithelial cells. Journal of Immunology 147(11): 3823-3830

Breviario, F.; Bertocchi, F.; Dejana, E.; Bussolino, F. 1988: IL-1-induced adhesion of polymorphonuclear leukocytes to cultured human endothelial cells. Role of platelet-activating factor. Journal of Immunology 141(10): 3391-3397

Warocquier-Clérout, R.; Penhoat, J.; Sigot-Luizard, M.F. 1991: IL-1-induced procoagulant and fibrinolytic activities of human endothelium grown on carbodiimide crosslinked proteins. Cytotechnology 7(3): 151-158

Yagisawa, H.; Kasahara, T.; Mukaida, N.; Yamashita, K.; Shioiri-Nakano, K. 1990: IL-1-induced production of IL-2 and IFN-gamma in subclones of human T-cell derived leukaemia HSB.2 cells: regulation by phytohaemagglutinin-mediated (poly)phosphoinositide breakdown and cyclic AMP. Immunology 71(2): 242-250

Bricio, T.; Molina, A.; Egido, J.; Gonzalez, E.; Mampaso, F. 1992: IL-1-like production in adriamycin-induced nephrotic syndrome in the rat. Clinical and Experimental Immunology 87(1): 117-121

Fiorentino, D.F.; Zlotnik, A.; Vieira, P.; Mosmann, T.R.; Howard, M.; Moore, K.W.; O'Garra, A. 1991: IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. Journal of Immunology 146(10): 3444-3451

Ghildyal, N.; McNeil, H.P.; Stechschulte, S.; Austen, K.F.; Silberstein, D.; Gurish, M.F.; Somerville, L.L.; Stevens, R.L. 1992: IL-10 induces transcription of the gene for mouse mast cell protease-1, a serine protease preferentially expressed in mucosal mast cells of Trichinella spiralis-infected mice. Journal of Immunology 149(6): 2123-2129

Fiorentino, D.F.; Zlotnik, A.; Mosmann, T.R.; Howard, M.; O'Garra, A. 1991: IL-10 inhibits cytokine production by activated macrophages. Journal of Immunology 147(11): 3815-3822

Taga, K.; Tosato, G. 1992: IL-10 inhibits human T cell proliferation and IL-2 production. Journal of Immunology 148(4): 1143-1148

Ding, L.; Shevach, E.M. 1992: IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage costimulatory function. Journal of Immunology 148(10): 3133-3139

Gazzinelli, R.T.; Oswald, I.P.; James, S.L.; Sher, A. 1992: IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages. Journal of Immunology 148(6): 1792-1796

O'Garra, A.; Howard, M. 1992: IL-10 production by CD5 B cells. Annals of the new York Academy of Sciences 651: 182-199

Lin, T.Z.; Fernandes, H.; Yauch, R.; Ponzio, N.M.; Raveche, E. 1992: IL-10 production in a CD5+ B cell lymphoma arising in a CD4 monoclonal antibody-treated SJL mouse. Clinical Immunology and Immunopathology 65(1): 10-22

Oswald, I.P.; Gazzinelli, R.T.; Sher, A.; James, S.L. 1992: IL-10 synergizes with IL-4 and transforming growth factor-beta to inhibit macrophage cytotoxic activity. Journal of Immunology 148(11): 3578-3582

Ralph, P.; Nakoinz, I.; Sampson-Johannes, A.; Fong, S.; Lowe, D.; Min, H.Y.; Lin, L. 1992: IL-10, T lymphocyte inhibitor of human blood cell production of IL-1 and tumor necrosis factor. Journal of Immunology 148(3): 808-814

MacNeil, I.A.; Suda, T.; Moore, K.W.; Mosmann, T.R.; Zlotnik, A. 1990: IL-10, a novel growth cofactor for mature and immature T cells. Journal of Immunology 145(12): 4167-4173

Chen, W.F.; Zlotnik, A. 1991: IL-10: a novel cytotoxic T cell differentiation factor. Journal of Immunology 147(2): 528-534

Chizzonite, R.; Truitt, T.; Desai, B.B.; Nunes, P.; Podlaski, F.J.; Stern, A.S.; Gately, M.K. 1992: IL-12 receptor. I. Characterization of the receptor on phytohemagglutinin-activated human lymphoblasts. Journal of Immunology 148(10): 3117-3124

Desai, B.B.; Quinn, P.M.; Wolitzky, A.G.; Mongini, P.K.; Chizzonite, R.; Gately, M.K. 1992: IL-12 receptor. II. Distribution and regulation of receptor expression. Journal of Immunology 148(10): 3125-3132

Chizzonite, R.; Truitt, T.; Podlaski, F.J.; Wolitzky, A.G.; Quinn, P.M.; Nunes, P.; Stern, A.S.; Gately, M.K. 1991: IL-12: monoclonal antibodies specific for the 40-kDa subunit block receptor binding and biologic activity on activated human lymphoblasts. Journal of Immunology 147(5): 1548-1556

Malyak, M.; Joslin, F.G.; Verderber, E.L.; Eisenberg, S.P.; Arend, W.P. 1991: IL-1ra ELISA: reduction and alkylation of synovial fluid eliminates interference by IgM rheumatoid factors. Journal of Immunological Methods 140(2): 281-288

Thompson, R.C.; Dripps, D.J.; Eisenberg, S.P. 1991: IL-1ra: properties and uses of an interleukin-1 receptor antagonist. Agents and Actions. Supplements 35: 41-49

Carron, J.A.; Cawley, J.C. 1991: IL-2 abolishes fibroblast proliferation in long-term bone marrow culture by inhibition of an accessory cell. British Journal of Haematology 79(3): 377-381

Slavin, S.; Ackerstein, A.; Kedar, E.; Weiss, L. 1990: IL-2 activated cell-mediated immunotherapy: control of minimal residual disease in malignant disorders by allogeneic lymphocytes and IL-2. Bone Marrow Transplantation 6(Suppl 1): 86-90

Kamholz, S.; Roslin, M.; Mondragon, M.; Coons, M.; Tranbaugh, R.; Strashun, A.; Manjoney, D.; Norin, A. 1991: IL-2 activated killer cell activity is associated with the early phase of allograft rejection. Transplantation Proceedings 23(1 Part 1): 597-598

Duke, R.C.; Cohen, J.J. 1986: IL-2 addiction: withdrawal of growth factor activates a suicide program in dependent T cells. Lymphokine Research 5(4): 289-299

Shibuya, H.; Yoneyama, M.; Ninomiya-Tsuji, J.; Matsumoto, K.; Taniguchi, T. 1992: IL-2 and EGF receptors stimulate the hematopoietic cell cycle via different signaling pathways: demonstration of a novel role for c-myc. Cell 70(1): 57-67

Maraskovsky, E.; Chen, W.F.; Shortman, K. 1989: IL-2 and IFN-gamma are two necessary lymphokines in the development of cytolytic T cells. Journal of Immunology 143(4): 1210-1214

Good, M.F.; Powell, L.W.; Halliday, J.W. 1989: IL-2 and IL-4 can co-modulate the generation of cytotoxic T cells through CD8- CD4- splenic lymphocytes. Immunology 67(2): 225-230

Takei, F. 1988: IL-2 and IL-4 stimulate different subpopulations of double-negative thymocytes. Journal of Immunology 141(4): 1114-1119

Takayasu, H.; Brooks, K.H. 1991: IL-2 and IL-5 both induce mu S and J chain mRNA in a clonal B cell line, but differ in their cell-cycle dependency for optimal signaling. Cellular Immunology 136(2): 472-485

Smyth, M.J.; Ortaldo, J.R.; Bere, W.; Yagita, H.; Okumura, K.; Young, H.A. 1990: IL-2 and IL-6 synergize to augment the pore-forming protein gene expression and cytotoxic potential of human peripheral blood T cells. Journal of Immunology 145(4): 1159-1166

Van Vlasselaer, P.; Gascan, H.; de Waal Malefyt, R.; de Vries, J.E. 1992: IL-2 and a contact-mediated signal provided by TCR alpha beta + or TCR gamma delta + CD4+ T cells induce polyclonal Ig production by committed human B cells. Enhancement by IL-5, specific inhibition of IgA synthesis by IL-4. Journal of Immunology 148(6): 1674-1684

Ishizaka, S.; Tsujii, T. 1989: IL-2 antibody production in lupus mice. Cellular Immunology 118(1): 100-107

Merida, I.; Diez, E.; Gaulton, G.N. 1991: IL-2 binding activates a tyrosine-phosphorylated phosphatidylinositol-3-kinase. Journal of Immunology 147(7): 2202-2207

Eichhorn, M.; Magnuson, N.S.; Reeves, R.; Williams, R.O.; Dobbelaere, D.A. 1990: IL-2 can enhance the cyclosporin A-mediated inhibition of Theileria parva-infected T cell proliferation. Journal of Immunology 144(2): 691-698

Houssiau, F.A.; Renauld, J.C.; Fibbe, W.E.; Van Snick, J. 1992: IL-2 dependence of IL-9 expression in human T lymphocytes. Journal of Immunology 148(10): 3147-3151

Splawski, J.B.; McAnally, L.M.; Lipsky, P.E. 1990: IL-2 dependence of the promotion of human B cell differentiation by IL-6 (BSF-2). Journal of Immunology 144(2): 562-569

Owen-Schaub, L.B.; de Mars, M.; Murphy, E.C.; Grimm, E.A. 1991: IL-2 dose regulates TNF-alpha mRNA transcription and protein secretion in human peripheral blood lymphocytes. Cellular Immunology 132(1): 193-200

Espinoza-Delgado, I.; Longo, D.L.; Gusella, G.L.; Varesio, L. 1990: IL-2 enhances c-fms expression in human monocytes. Journal of Immunology 145(4): 1137-1143

Tomura, K.; Kang, H.; Mitamura, K.; Takei, M.; Karasaki, M.; Koyasu, S.; Sawada, S. 1989: IL-2 enhancing factor(s) in B cell supernatants from patients with rheumatoid arthritis or systemic lupus erythematosus. Tohoku Journal of Experimental Medicine 159(3): 171-183

Meloni, G.; Foa, R.; Capria, S.; Tosti, S.; Vignetti, M.; Gavosto, F.; Mandelli, F. 1992: IL-2 for the treatment of acute leukemias. Leukemia 6(Suppl 2): 28-30

Roth, C.; Mir, L.; Cressent, M.; Quintin-Colonna, F.; Ley, V.; Fradelizi, D.; Kourilsky, P. 1992: IL-2 gene transduction in malignant cells: applications in cancer containment. Bone Marrow Transplantation 9(Suppl 1): 174-175

Bubeník, J.; Lotzová, E.; Indrová, M.; Simová, J.; Jandlová, T.; Savary, C.A. 1991: IL-2 gene transfer in immunotherapy of cancer: local administration of IL-2-activated lymphocytes and X63-m-IL-2 cells constitutively producing IL-2 inhibits growth of plasmacytomas in syngeneic mice. Natural Immunity and Cell Growth Regulation 10(5): 247-255

Meloni, G.; Foà, R.; Tosti, S.; Vignetti, M.; Gavosto, F.; Mandelli, F. 1990: IL-2 in the treatment of chronic myeloid leukemia after lymphoid blast crisis: a pilot study. Haematologica 75(6): 502-505

Musso, T.; Espinoza-Delgado, I.; Pulkki, K.; Gusella, G.L.; Longo, D.L.; Varesio, L. 1992: IL-2 induces IL-6 production in human monocytes. Journal of Immunology 148(3): 795-800

Manyak, C.L.; Norton, G.P.; Lobe, C.G.; Bleackley, R.C.; Gershenfeld, H.K.; Weissman, I.L.; Kumar, V.; Sigal, N.H.; Koo, G.C. 1989: IL-2 induces expression of serine protease enzymes and genes in natural killer and nonspecific T killer cells. Journal of Immunology 142(10): 3707-3713

Ferro, T.J.; Johnson, A.; Everitt, J.; Malik, A.B. 1989: IL-2 induces pulmonary edema and vasoconstriction independent of circulating lymphocytes. Journal of Immunology 142(6): 1916-1921

Kovacs, E.J.; Brock, B.; Varesio, L.; Young, H.A. 1989: IL-2 induction of IL-1 beta mRNA expression in monocytes. Regulation by agents that block second messenger pathways. Journal of Immunology 143(11): 3532-3537

Madar, J.; Asherson, G.L.; Colizzi, V.; Zembala, M. 1988: IL-2 influences the balance between immunity and unresponsiveness in the picryl (TNP) contact sensitivity system by blocking the development or action of an Lyt-2+, I-J+ T suppressor cell. Cellular Immunology 117(1): 209-217

Gottlieb, D.J.; Prentice, H.G.; Heslop, H.E.; Bello, C.; Brenner, M.K. 1992: IL-2 infusion abrogates humoral immune responses in humans. Clinical and Experimental Immunology 87(3): 493-498

Peuchmaur, M.; Emilie, D.; Crevon, M.C.; Solal-Celigny, P.; Maillot, M.C.; Lemaigre, G.; Galanaud, P. 1990: IL-2 mRNA expression in Tac-positive malignant lymphomas. American Journal of Pathology 136(2): 383-390

Seldin, M.F.; Mountz, J.D.; Mushinski, J.F.; Smith, H.R.; Steinberg, A.D. 1987: IL-2 modulation of murine T-cell oncogene expression. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 184(2): 186-190

Volk, H.D.; Diamantstein, T. 1986: IL-2 normalizes defective suppressor T cell function of patients with systemic lupus erythematosus in vitro. Clinical and Experimental Immunology 66(3): 525-531

Dorval, T.; Mathiot, C.; Chosidow, O.; Revuz, J.; Avril, M.F.; Guillaume, J.C.; Tursz, T.; Brandely, M.; Pouillart, P.; Fridman, W.H. 1992: IL-2 phase Ii trial in metastatic melanoma: analysis of clinical and immunological parameters. Biotechnology Therapeutics 3(1-2): 63-79

Wu, J.; Wang, M.L.; Qiu, S.L.; Han, J.K.; Zhu, D.X. 1992: IL-2 potentiates the IL-3 production by ConA activated mouse splenic T cells. Shi Yan Sheng Wu Xue Bao 25(1): 25-30

Reuben, J.M.; Hersh, E.M.; Murray, J.L.; Munn, C.G.; Mehta, S.R.; Mansell, P.W. 1985: IL-2 production and response in vitro by the leukocytes of patients with acquired immune deficiency syndrome. Lymphokine Research 4(2): 103-116

Kakiuchi, T.; Tamura, T.; Gyotoku, Y.; Nariuchi, H. 1991: IL-2 production by B cells stimulated with a specific antigen. Cellular Immunology 138(1): 207-215

Pullman, W.E.; Doe, W.F. 1992: IL-2 production by intestinal lamina propria cells in normal inflamed and cancer-bearing colons. Clinical and Experimental Immunology 88(1): 132-137

Reinhold, D.; Ansorge, S. 1990: IL-2 production by peripheral blood mononuclear cells after stimulation with pokeweed mitogen. Allergie und Immunologie 36(4): 293-298

Goebels, N.; Waase, I.; Pfizenmaier, K.; Krönke, M. 1988: IL-2 production in human T lymphotropic virus I-infected leukemic T lymphocytes analyzed by in situ hybridization. Journal of Immunology 141(4): 1231-1235

Oen, K.; Warrington, R.; Rosenberg, A.M.; Krzekotowska, D. 1988: IL-2 production in the autologous mixed lymphocyte reaction of patients with juvenile rheumatoid arthritis. Clinical and Experimental Immunology 74(1): 87-93

Zhu, D.H.; Bell, R.G. 1989: IL-2 production, IL-2 receptor expression, and IL-2 responsiveness of spleen and mesenteric lymph node cells from inbred mice infected with Trichinella spiralis. Journal of Immunology 142(9): 3262-3267

Fernández-Ruiz, E.; Rebollo, A.; Nieto, M.A.; Sanz, E.; Somoza, C.; Ramirez, F.; Lopez-Rivas, A.; Silva, A. 1989: IL-2 protects T cell hybrids from the cytolytic effect of glucocorticoids. Synergistic effect of IL-2 and dexamethasone in the induction of high-affinity IL-2 receptors. Journal of Immunology 143(12): 4146-4151

Nieto, M.A.; López-Rivas, A. 1989: IL-2 protects T lymphocytes from glucocorticoid-induced DNA fragmentation and cell death. Journal of Immunology 143(12): 4166-4170

Nieto, M.A.; González, A.; López-Rivas, A.; Diaz-Espada, F.; Gambón, F. 1990: IL-2 protects against anti-CD3-induced cell death in human medullary thymocytes. Journal of Immunology 145(5): 1364-1368

Aronson, F.R.; Libby, P.; Brandon, E.P.; Janicka, M.W.; Mier, J.W. 1988: IL-2 rapidly induces natural killer cell adhesion to human endothelial cells. a potential mechanism for endothelial injury. Journal of Immunology 141(1): 158-163

Yodoi, J.; Tagaya, Y.; Masutani, H.; Maeda, Y.; Kawabe, T. 1988: IL-2 receptor and Fc epsilon R2 gene activation in lymphocyte transformation: possible roles of ATL-derived factor. Princess Takamatsu Symposia 19: 73-86

Tournier-Lasserve, E.; Lyoncaen, O.; Roullet, E.; Bach, M.A. 1987: IL-2 receptor and HLA class Ii antigens on cerebrospinal fluid cells of patients with multiple sclerosis and other neurological diseases. Clinical and Experimental Immunology 67(3): 581-586

Yodoi, J.; Uchiyama, T. 1986: IL-2 receptor dysfunction and adult T-cell leukemia. Immunological Reviews 92: 135-156

Saito, S.; Fujii, M.; Saito, M.; Kato, Y.; Moriyama, I.; Ichijo, M. 1989: IL-2 receptor expression and function on human cord blood mononuclear cells following PHA and anti-CD3 antibody stimulation. Journal of Reproductive Immunology 16(1): 31-42

Strauchen, J.A.; Breakstone, B.A. 1987: IL-2 receptor expression in human lymphoid lesions. Immunohistochemical study of 166 cases. American Journal of Pathology 126(3): 506-512

Waldmann, T.A. 1989: IL-2 receptor expression in the haematologic malignancies: a target for immunotherapy. Cancer Surveys 8(4): 891-903

Yodoi, J.; Okada, M.; Tagaya, Y.; Taniguchi, Y.; Teshigawara, K.; Kasahara, T.; Dinarello, C.A.; Matsushima, K.; Honko, T.; Uchiyama, T. 1987: IL-2 receptor gene activation by ATL-derived factor (ADF). Advances in Experimental Medicine and Biology 213: 139-148

Boyer, P.D.; Rothenberg, E.V. 1988: IL-2 receptor inducibility is blocked in cortical-type thymocytes. Journal of Immunology 140(9): 2886-2892

Suzuki, J.; Takeshita, T.; Ohbo, K.; Asao, H.; Tada, K.; Sugamura, K. 1989: IL-2 receptor subunit, p75: direct demonstration of its IL-2 binding ability by using a novel monoclonal antibody. International Immunology 1(4): 373-377

Tagaya, Y.; Okada, M.; Sugie, K.; Kasahara, T.; Kondo, N.; Hamuro, J.; Matsushima, K.; Dinarello, C.A.; Yodoi, J. 1988: IL-2 receptor(p55)/Tac-inducing factor. Purification and characterization of adult T cell leukemia-derived factor. Journal of Immunology 140(8): 2614-2620

Waldmann, T.A.; Kozak, R.W.; Tsudo, M.; Oh-ishi, T.; Bongiovanni, K.F.; Goldman, C.K. 1987: IL-2 receptors in adult T-cell leukemia: a target for immunotherapy. Haematology and Blood Transfusion 31: 110-115

Ben Aribia, M.H.; Moiré, N.; Métivier, D.; Vaquero, C.; Lantz, O.; Olive, D.; Charpentier, B.; Senik, A. 1989: IL-2 receptors on circulating natural killer cells and T lymphocytes. Similarity in number and affinity but difference in transmission of the proliferation signal. Journal of Immunology 142(2): 490-499

Yamamura, Y.; Kotani, M.; Tsudo, M.; Karasuyama, H.; Seto, A.; Miyasaka, M. 1990: IL-2 receptors on rabbit T-cell lines and their transfectants expressing the human IL-2 receptor alpha chain. Immunology 71(4): 502-507

Mazzarino, C.; Nicosia, A.; Monte, V.; Petralia, S.; Garraffo, C.; Girlando, A.; Santoro, S.; Malaponte, G. 1990: IL-2 receptors, NK and LAK cytotoxicity of lymphocytes in breast carcinoma during prolonged thymopentin therapy. Journal of Nuclear Medicine and Allied Sciences 34(4 Suppl): 161-162

Ferris, D.K.; Willette-Brown, J.; Ortaldo, J.R.; Farrar, W.L. 1989: IL-2 regulation of tyrosine kinase activity is mediated through the p70-75 beta-subunit of the IL-2 receptor. Journal of Immunology 143(3): 870-876

Osawa, J. 1990: IL-2 responsiveness in antigen-specific lymphocyte proliferation test with sulfhydryl drug-sensitized murine lymphocytes--using rapid fluorochromasia assay. Nihon Hifuka Gakkai Zasshi. Japanese Journal of Dermatology 100(12): 1235-1240

Hornung, N.; Raskova, J.; Raska, K.; Degiannis, D. 1992: IL-2 responsiveness of lectin-induced lymphoblasts: soluble IL-2 receptor release and differential in vitro effects of immunosuppressants. International Journal of Immunopharmacology 14(5): 753-760

Tentori, L.; Leonetti, C.; Lanzilli, G.; Bonmassar, E. 1990: IL-2 reverses the inhibition of cytotoxic T-cell responses induced by 5-(3,3' dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC) in vitro. International Journal of Immunopharmacology 12(8): 831-840

Norton, S.D.; Hovinen, D.E.; Jenkins, M.K. 1991: IL-2 secretion and T cell clonal anergy are induced by distinct biochemical pathways. Journal of Immunology 146(4): 1125-1129

Stanley, J.B.; Gorczynski, R.M.; Delovitch, T.L.; Mills, G.B. 1989: IL-2 secretion is pertussis toxin sensitive in a T lymphocyte hybridoma. Journal of Immunology 142(10): 3546-3552

Numerof, R.P.; Aronson, F.R.; Mier, J.W. 1988: IL-2 stimulates the production of IL-1 alpha and IL-1 beta by human peripheral blood mononuclear cells. Journal of Immunology 141(12): 4250-4257

Minamoto, S.; Taniguchi, T. 1991: IL-2 system in B lymphocyte growth and differentiation. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 36(4): 673-678

Meitner, P.A. 1991: The fluorescent cytoprint assay: a new approach to in vitro chemosensitivity testing. Oncology 5(9): 75-81; Discussion: 81-82 85, 88

Tiberghien, P.; Racadot, E.; Fest, T.; Lioure, B.; Pariset, J.; Delain, M.; Voillat, L.; Flesch, M.; Amsallem, D.; Plouvier, E. 1991: IL-2 treatment after autologous bone marrow transplantation in poor prognosis Hodgkin's disease: defective IL-2-induced LAK activity?. Bone Marrow Transplantation 7(Suppl 2): 145

Ahmed, K.; Vianna, J.L.; Khamashta, M.A.; Hughes, G.R. 1992: IL-2, IL-6 and TNF levels in primary antiphospholipid syndrome. Clinical and Experimental Rheumatology 10(5): 503

Hodgkin, P.D.; Cupp, J.; Zlotnik, A.; Howard, M. 1990: IL-2, IL-6, and IFN-gamma have distinct effects on the IL-4 plus PMA-induced proliferation of thymocyte subpopulations. Cellular Immunology 126(1): 57-68

Sherblom, A.P.; Sathyamoorthy, N.; Decker, J.M.; Muchmore, A.V. 1989: IL-2, a lectin with specificity for high mannose glycopeptides. Journal of Immunology 143(3): 939-944

Braakman, E.; van Tunen, A.; Meager, A.; Lucas, C.J. 1986: IL-2- and IFN gamma-enhanced natural cytotoxic activity: analysis of the role of different lymphoid subsets and implications for activation routes. Cellular Immunology 99(2): 476-488

Katoh, T.; Harada, T.; Morikawa, S.; Wakutani, T. 1986: IL-2- and IL-2-R- independent proliferation of T-cell lines from adult T-cell leukemia/lymphoma patients. International Journal of Cancer 38(2): 265-274

Ogata, M.; Lorberboum-Galski, H.; FitzGerald, D.; Pastan, I. 1988: IL-2-PE40 is cytotoxic for activated T lymphocytes expressing IL-2 receptors. Journal of Immunology 141(12): 4224-4228

Kozak, R.W.; Lorberboum-Galski, H.; Jones, L.; Puri, R.K.; Willingham, M.C.; Malek, T.; Fitzgerald, D.J.; Waldmann, T.A.; Pastan, I. 1990: IL-2-PE40 prevents the development of tumors in mice injected with IL-2 receptor expressing EL4 transfectant tumor cells. Journal of Immunology 145(8): 2766-2771

Moire, N.; Rouleau, M.; Metivier, D.; Charpentier, B.; Senik, A. 1991: IL-2-R beta expression and function within resting CD8+ T cells preferentially segregate with the CD45R0+ subset. European Cytokine Network 2(5): 319-327

Damle, N.K.; Doyle, L.V. 1989: IL-2-activated human killer lymphocytes but not their secreted products mediate increase in albumin flux across cultured endothelial monolayers. Implications for vascular leak syndrome. Journal of Immunology 142(8): 2660-2669

Jablons, D.; Bolton, E.; Mertins, S.; Rubin, M.; Pizzo, P.; Rosenberg, S.A.; Lotze, M.T. 1990: IL-2-based immunotherapy alters circulating neutrophil Fc receptor expression and chemotaxis. Journal of Immunology 144(9): 3630-3636

Yamada, Y.; Nagata, Y.; Kamihira, S.; Tagawa, M.; Ichimaru, M.; Tomonaga, M.; Shiku, H. 1991: IL-2-dependent ATL cell lines with phenotypes differing from the original leukemia cells. Leukemia Research 15(7): 619-625

Colamonici, O.R.; Ang, S.; Quinones, R.; Henkart, P.; Heikkila, R.; Gress, R.; Felix, C.; Kirsch, I.; Longo, D.; Marti, G. 1988: IL-2-dependent expansion of CD3+ large granular lymphocytes expressing T cell receptor-gamma delta. Evidence for a functional receptor by anti-CD3 activation of cytolysis. Journal of Immunology 140(8): 2527-2533

Migliorati, G.; Moraca, R.; Nicoletti, I.; Riccardi, C. 1992: IL-2-dependent generation of natural killer cells from bone marrow: role of MAC-1-, NK1-1- precursors. Cellular Immunology 141(2): 323-331

Asao, H.; Kumaki, S.; Takeshita, T.; Nakamura, M.; Sugamura, K. 1992: IL-2-dependent in vivo and in vitro tyrosine phosphorylation of IL-2 receptor gamma chain. Febs Letters 304(2-3): 141-145

Morkowski, J.J.; Nanno, M.; Chen, P.F.; Itoh, K.; Ioannides, C.G.; Kruzel, E.; Becker, F.F.; Platsoucas, C.D. 1991: IL-2-dependent murine T-cell lines and clones expressing gamma/delta T-cell antigen receptors. I. Functional and biochemical characterization. Scandinavian Journal of Immunology 34(6): 779-794

Jankovic, D.L.; Rebollo, A.; Kumar, A.; Gibert, M.; Thèze, J. 1990: IL-2-dependent proliferation of murine T cells requires expression of both the p55 and p70 subunits of the IL-2 receptor. Journal of Immunology 145(12): 4136-4144

Rocha, B.; Lehuen, A.; Papiernik, M. 1988: IL-2-dependent proliferation of thymic accessory cells. Journal of Immunology 140(4): 1076-1080

Mookerjee, B.K.; Chen, P.B.; Pauly, J.L. 1989: IL-2-induced polyclonal proliferation of human peripheral blood lymphocytes: functional and phenotypic characteristics of proliferating cells. Immunology 66(2): 176-182

Arima, N.; Kuziel, W.A.; Grdina, T.A.; Greene, W.C. 1992: IL-2-induced signal transduction involves the activation of nuclear NF-kappa B expression. Journal of Immunology 149(1): 83-91

Sugamura, K.; Takeshita, T.; Asao, H.; Kumaki, S.; Ohbo, K.; Ohtani, K.; Nakamura, M. 1990: IL-2-induced signal transduction: involvement of tyrosine kinase and IL-2 receptor gamma chain. Lymphokine Research 9(4): 539-542

Bujdoso, R.; Young, P.; Hopkins, J.; McConnell, I. 1990: IL-2-like activity in lymph fluid following in vivo antigen challenge. Immunology 69(1): 45-51

Belosevic, M.; Finbloom, D.S.; Meltzer, M.S.; Nacy, C.A. 1990: IL-2. a cofactor for induction of activated macrophage resistance to infection. Journal of Immunology 145(3): 831-839

Auber, M.L.; DeHaven, J.I.; Raich, P.C.; Rogers, J.S.; Crowell, E.B.; Romero, P.; Mahin, E.J.; Sosnowski, J.T.; Lamm, D.L. 1991: IL-2/LAK cell treatment for advanced cancers with emphasis on a novel administration. West Virginia Medical Journal 87(8): 344-346

Anonymous 1989: IL-2/TIL therapy: more effective for advanced melanoma. Oncology 3(3): 117

Oldham, R.K.; Maleckar, J.R.; Yannelli, J.R.; West, W.H. 1989: IL-2: a review of current knowledge. Cancer Treatment Reviews 16 Suppl A: 5-13

Louie, A. 1990: IL-2: efficacy in renal cell carcinoma and overall safety profile. Cancer Investigation 8(2): 315-316

Padavic-Shaller, K. 1988: IL-2: nursing applications in a developing science. Seminars in Oncology Nursing 4(2): 142-150

Bradford, P.G.; Jin, Y.; Hui, P.; Wang, X. 1992: IL-3 and GM-CSF induce the expression of the inositol trisphosphate receptor in K562 myeloblast cells. Biochemical and Biophysical Research Communications 187(1): 438-442

Wood, P.M.; Jordan, R.K.; Givan, A.L.; Brooks, C.G. 1990: IL-3 and IL-4 affect thymocyte differentiation in organ culture. Immunology 71(1): 83-89

Takafuji, S.; Bischoff, S.C.; De Weck, A.L.; Dahinden, C.A. 1991: IL-3 and IL-5 prime normal human eosinophils to produce leukotriene C4 in response to soluble agonists. Journal of Immunology 147(11): 3855-3861

Elliott, M.J.; Vadas, M.A.; Cleland, L.G.; Gamble, J.R.; Lopez, A.F. 1990: IL-3 and granulocyte-macrophage colony-stimulating factor stimulate two distinct phases of adhesion in human monocytes. Journal of Immunology 145(1): 167-176

Rennick, D.; Jackson, J.; Moulds, C.; Lee, F.; Yang, G. 1989: IL-3 and stromal cell-derived factor synergistically stimulate the growth of pre-B cell lines cloned from long-term lymphoid bone marrow cultures. Journal of Immunology 142(1): 161-166

Bochner, B.S.; McKelvey, A.A.; Sterbinsky, S.A.; Hildreth, J.E.; Derse, C.P.; Klunk, D.A.; Lichtenstein, L.M.; Schleimer, R.P. 1990: IL-3 augments adhesiveness for endothelium and CD11b expression in human basophils but not neutrophils. Journal of Immunology 145(6): 1832-1837

Millet, I.; Ferreri, N.R.; Ramabhadran, R.; Askenase, P.W. 1992: IL-3 dependence of a Thy-1lo, B220+, IL-3 receptor-positive antigen-specific DTH-initiating clone. Cellular Immunology 143(1): 154-169

Nefesh, I.; Bauskin, A.R.; Alkalay, I.; Golembo, M.; Ben-Neriah, Y. 1991: IL-3 facilitates lymphocyte hexose transport by enhancing the intrinsic activity of the transport system. International Immunology 3(8): 827-831

Muto, A.; Yokota, T. 1992: IL-3 gene, receptor and signal transduction. Nihon Rinsho. Japanese Journal of Clinical Medicine 50(8): 1781-1786

Barton, B.E.; Mayer, R. 1989: IL-3 induces differentiation of bone marrow precursor cells to osteoclast-like cells. Journal of Immunology 143(10): 3211-3216

Onetto-Pothier, N.; Aumont, N.; Haman, A.; Park, L.; Clark, S.C.; De Léan, A.; Hoang, T. 1990: IL-3 inhibits the binding of GM-CSF to AML blasts, but the two cytokines act synergistically in supporting blast proliferation. Leukemia 4(5): 329-336

Kubo, M.; Cinader, B. 1990: IL-3 production as a function of age and its correlation with splenomegaly: age versus disease-related change. Immunology Letters 24(2): 133-136

Valent, P.; Besemer, J.; Kishi, K.; Kaltenbrunner, R.; Kuhn, B.; Maurer, D.; Lechner, K.; Bettelheim, P. 1990: IL-3 promotes basophilic differentiation of KU812 cells through high affinity binding sites. Journal of Immunology 145(6): 1885-1889

Le Gros, G.; Ben-Sasson, S.Z.; Conrad, D.H.; Clark-Lewis, I.; Finkelman, F.D.; Plaut, M.; Paul, W.E. 1990: IL-3 promotes production of IL-4 by splenic non-B, non-T cells in response to Fc receptor cross-linkage. Journal of Immunology 145(8): 2500-2506

Taketazu, F.; Chiba, S.; Shibuya, K.; Kuwaki, T.; Tsumura, H.; Miyazono, K.; Miyagawa, K.; Takaku, F. 1991: IL-3 specifically inhibits GM-CSF binding to the higher affinity receptor. Journal of Cellular Physiology 146(2): 251-257

Akinsanya, A.A.; Whetton, A.D. 1992: IL-3 stimulated haemopoietic stem cell proliferation: evidence for G protein independent mitogenic signalling events. Journal of Cellular Physiology 152(2): 245-252

Holda, J.H.; Maier, T.; Claman, H.N. 1990: IL-3, IL-4, and IL-6 enhance IFN-gamma-dependent bone marrow natural suppressor activity. Cellular Immunology 125(2): 459-468

Kirshenbaum, A.S.; Goff, J.P.; Dreskin, S.C.; Irani, A.M.; Schwartz, L.B.; Metcalfe, D.D. 1989: IL-3-dependent growth of basophil-like cells and mastlike cells from human bone marrow. Journal of Immunology 142(7): 2424-2429

Pelech, S.L.; Paddon, H.B.; Charest, D.L.; Federsppiel, B.S. 1990: IL-3-induced activation of protein kinases in the mast cell/megakaryocyte R6-XE.4 line. Journal of Immunology 144(5): 1759-1766

Robinson, M.; Chen, T.; Warne, T.R. 1991: IL-3-induced generation of alkylacylglycerol and diacylglycerol in an IL-3-dependent cell line. Journal of Immunology 147(8): 2624-2629

Nishida, J.; Yokota, T.; Miyajima, A. 1991: IL-3: production mechanism and the receptor. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 36(7): 1159-1167

Xia, Y.N.; Burbank, D.E.; Uher, L.; Rabussay, D.; Van Etten, J.L. 1987: IL-3A virus infection of a Chlorella-like green alga induces a DNA restriction endonuclease with novel sequence specificity. Nucleic Acids Research 15(15): 6075-6090

Carding, S.R.; Bottomly, K. 1988: IL-4 (B cell stimulatory factor 1) exhibits thymocyte growth factor activity in the presence of IL-2. Journal of Immunology 140(5): 1519-1526

Phillips, N.E.; Gravel, K.A.; Tumas, K.; Parker, D.C. 1988: IL-4 (B cell stimulatory factor 1) overcomes Fc gamma receptor-mediated inhibition of mouse B lymphocyte proliferation without affecting inhibition of c-myc mRNA induction. Journal of Immunology 141(12): 4243-4249

Horohov, D.W.; Crim, J.A.; Smith, P.L.; Siegel, J.P. 1988: IL-4 (B cell-stimulatory factor 1) regulates multiple aspects of influenza virus-specific cell-mediated immunity. Journal of Immunology 141(12): 4217-4223

Bello-Fernandez, C.; Oblakowski, P.; Meager, A.; Duncombe, A.S.; Rill, D.M.; Hoffbrand, A.V.; Brenner, M.K. 1991: IL-4 acts as a homeostatic regulator of IL-2-induced TNF and IFN-gamma. Immunology 72(2): 161-166

Vandenabeele, P.; Grooten, J.; Fiers, W. 1990: IL-4 acts synergistically on the IL-2 response of an autoreactive T-cell clone; synergism correlates with increased intracellular IL-2, but not with a modified IL-2 receptor expression. Cellular Immunology 130(1): 79-91

Masinovsky, B.; Urdal, D.; Gallatin, W.M. 1990: IL-4 acts synergistically with IL-1 beta to promote lymphocyte adhesion to microvascular endothelium by induction of vascular cell adhesion molecule-1. Journal of Immunology 145(9): 2886-2895

Zubiaga, A.M.; Munoz, E.; Huber, B.T. 1992: IL-4 and IL-2 selectively rescue Th cell subsets from glucocorticoid-induced apoptosis. Journal of Immunology 149(1): 107-112

Vallé, A.; Aubry, J.P.; Durand, I.; Banchereau, J. 1991: IL-4 and IL-2 upregulate the expression of antigen B7, the B cell counterstructure to T cell CD28: an amplification mechanism for T-B cell interactions. International Immunology 3(3): 229-235

Gerrard, T.L.; Dyer, D.R.; Mostowski, H.S. 1990: IL-4 and granulocyte-macrophage colony-stimulating factor selectively increase HLA-DR and HLA-DP antigens but not HLA-DQ antigens on human monocytes. Journal of Immunology 144(12): 4670-4674

Ninomiya, C.; Spiegelberg, H.L. 1992: IL-4 and transforming growth factor-beta suppress human immunoglobulin secretion in vitro by surface IgD- B cells. Clinical and Experimental Immunology 89(2): 261-268

Wong, H.L.; Welch, G.R.; Brandes, M.E.; Wahl, S.M. 1991: IL-4 antagonizes induction of Fc gamma RIIi (CD16) expression by transforming growth factor-beta on human monocytes. Journal of Immunology 147(6): 1843-1848

Lee, H.K.; Xia, X.; Choi, Y.S. 1990: IL-4 blocks the up-regulation of IL-2 receptors induced by IL-2 in normal human B cells. Journal of Immunology 144(9): 3431-3436

Heeg, K.; Gillis, S.; Wagner, H. 1988: IL-4 bypasses the immune suppressive effect of cyclosporin a during the in vitro induction of murine cytotoxic T lymphocytes. Journal of Immunology 141(7): 2330-2334

Savelkoul, H.F.; Seymour, B.W.; Sullivan, L.; Coffman, R.L. 1991: IL-4 can correct defective IgE production in SJA/9 mice. Journal of Immunology 146(6): 1801-1805

Taieb, J.; Leca, G.; Auffredou, M.T.; Galanaud, P.; Vazquez, A. 1991: IL-4 counteracts anti-mu-induced human B cell proliferation: involvement of a cAMP-dependent inhibitory pathway. European Cytokine Network 2(4): 265-272

Te Velde, A.A.; Huijbens, R.J.; de Vries, J.E.; Figdor, C.G. 1990: IL-4 decreases Fc gamma R membrane expression and Fc gamma R-mediated cytotoxic activity of human monocytes. Journal of Immunology 144(8): 3046-3051

Renkonen, R.; Mattila, P.; Majuri, M.L.; Paavonen, T.; Silvennoinen, O. 1992: IL-4 decreases IFN-gamma-induced endothelial ICAM-1 expression by a transcriptional mechanism. Scandinavian Journal of Immunology 35(5): 525-530

Ruppert, J.; Friedrichs, D.; Xu, H.; Peters, J.H. 1991: IL-4 decreases the expression of the monocyte differentiation marker CD14, paralleled by an increasing accessory potency. Immunobiology 182(5): 449-464

Swain, S.L.; Weinberg, A.D.; English, M.; Huston, G. 1990: IL-4 directs the development of Th2-like helper effectors. Journal of Immunology 145(11): 3796-3806

Essner, R.; Rhoades, K.; McBride, W.H.; Morton, D.L.; Economou, J.S. 1989: IL-4 down-regulates IL-1 and TNF gene expression in human monocytes. Journal of Immunology 142(11): 3857-3861

Ishikawa, T.; Uchiyama, T.; Kamio, M.; Onishi, R.; Kodaka, T.; Okuma, M. 1991: IL-4 down-regulates IL-2 receptor p75 by accelerating its endocytosis. International Immunology 3(6): 517-525

Yin, X.M.; Vitetta, E.S. 1991: IL-4 down-regulates the expression of J11d on murine B cells. Cellular Immunology 137(2): 461-473

Hidaka, T.; Kitani, A.; Hara, M.; Harigai, M.; Suzuki, K.; Kawaguchi, Y.; Ishizuka, T.; Kawagoe, M.; Nakamura, H. 1992: IL-4 down-regulates the surface expression of CD5 on B cells and inhibits spontaneous immunoglobulin and IgM-rheumatoid factor production in patients with rheumatoid arthritis. Clinical and Experimental Immunology 89(2): 223-229

Mangan, D.F.; Robertson, B.; Wahl, S.M. 1992: IL-4 enhances programmed cell death (apoptosis) in stimulated human monocytes. Journal of Immunology 148(6): 1812-1816

Tanaka, T.; Ben-Sasson, S.Z.; Paul, W.E. 1991: IL-4 increases IL-2 production by T cells in response to accessory cell-independent stimuli. Journal of Immunology 146(11): 3831-3839

Thornhill, M.H.; Kyan-Aung, U.; Haskard, D.O. 1990: IL-4 increases human endothelial cell adhesiveness for T cells but not for neutrophils. Journal of Immunology 144(8): 3060-3065

Casey, L.S.; Lichtman, A.H.; Boothby, M. 1992: IL-4 induces IL-2 receptor p75 beta-chain gene expression and IL-2-dependent proliferation in mouse T lymphocytes. Journal of Immunology 148(11): 3418-3426

Rousset, F.; Billaud, M.; Blanchard, D.; Figdor, C.; Lenoir, G.M.; Spits, H.; De Vries, J.E. 1989: IL-4 induces LFA-1 and LFA-3 expression on Burkitt's lymphoma cell lines. Requirement of additional activation by phorbol myristate acetate for induction of homotypic cell adhesions. Journal of Immunology 143(5): 1490-1498

Chatelain, R.; Varkila, K.; Coffman, R.L. 1992: IL-4 induces a Th2 response in Leishmania major-infected mice. Journal of Immunology 148(4): 1182-1187

Schleimer, R.P.; Sterbinsky, S.A.; Kaiser, J.; Bickel, C.A.; Klunk, D.A.; Tomioka, K.; Newman, W.; Luscinskas, F.W.; Gimbrone, M.A.; McIntyre, B.W. 1992: IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium. Association with expression of VCAM-1. Journal of Immunology 148(4): 1086-1092

Tepper, R.I.; Levinson, D.A.; Stanger, B.Z.; Campos-Torres, J.; Abbas, A.K.; Leder, P. 1990: IL-4 induces allergic-like inflammatory disease and alters T cell development in transgenic mice. Cell 62(3): 457-467

Snapper, C.M.; Finkelman, F.D.; Stefany, D.; Conrad, D.H.; Paul, W.E. 1988: IL-4 induces co-expression of intrinsic membrane IgG1 and IgE by murine B cells stimulated with lipopolysaccharide. Journal of Immunology 141(2): 489-498

Dancescu, M.; Wu, C.; Rubio, M.; Delespesse, G.; Sarfati, M. 1992: IL-4 induces conformational change of CD20 antigen via a protein kinase C-independent pathway. Antagonistic effect of anti-CD40 monoclonal antibody. Journal of Immunology 148(8): 2411-2416

Laszlo, G.; Dickler, H.B. 1988: IL-4 induces loss of B lymphocyte Fc gamma R Ii ligand binding capacity. Journal of Immunology 141(10): 3416-3421

Lehn, M.; Weiser, W.Y.; Engelhorn, S.; Gillis, S.; Remold, H.G. 1989: IL-4 inhibits H2O2 production and antileishmanial capacity of human cultured monocytes mediated by IFN-gamma. Journal of Immunology 143(9): 3020-3024

Martinez, O.M.; Gibbons, R.S.; Garovoy, M.R.; Aronson, F.R. 1990: IL-4 inhibits IL-2 receptor expression and IL-2-dependent proliferation of human T cells. Journal of Immunology 144(6): 2211-2215

Gayá, A.; de la Calle, O.; Yagüe, J.; Alsinet, E.; Fernández, M.D.; Romero, M.; Fabregat, V.; Martorell, J.; Vives, J. 1991: IL-4 inhibits IL-2 synthesis and IL-2-induced up-regulation of IL-2R alpha but not IL-2R beta chain in CD4+ human T cells. Journal of Immunology 146(12): 4209-4214

Spits, H.; Yssel, H.; Paliard, X.; Kastelein, R.; Figdor, C.; de Vries, J.E. 1988: IL-4 inhibits IL-2-mediated induction of human lymphokine-activated killer cells, but not the generation of antigen-specific cytotoxic T lymphocytes in mixed leukocyte cultures. Journal of Immunology 141(1): 29-36

Herbert, J.M.; Savi, P.; Laplace, M.C.; Lale, A. 1992: IL-4 inhibits LPS-, IL-1 beta- and TNF alpha-induced expression of tissue factor in endothelial cells and monocytes. Febs Letters 310(1): 31-33

Kumaratilake, L.M.; Ferrante, A. 1992: IL-4 inhibits macrophage-mediated killing of Plasmodium falciparum in vitro. a possible parasite-immune evasion mechanism. Journal of Immunology 149(1): 194-199

Abramson, S.L.; Gallin, J.I. 1990: IL-4 inhibits superoxide production by human mononuclear phagocytes. Journal of Immunology 144(2): 625-630

Cox, G.W.; Chattopadhyay, U.; Oppenheim, J.J.; Varesio, L. 1991: IL-4 inhibits the costimulatory activity of IL-2 or picolinic acid but not of lipopolysaccharide on IFN-gamma-treated macrophages. Journal of Immunology 147(11): 3809-3814

Standiford, T.J.; Strieter, R.M.; Chensue, S.W.; Westwick, J.; Kasahara, K.; Kunkel, S.L. 1990: IL-4 inhibits the expression of IL-8 from stimulated human monocytes. Journal of Immunology 145(5): 1435-1439

Karray, S.; Dautry-Varsat, A.; Tsudo, M.; Merle-Beral, H.; Debre, P.; Galanaud, P. 1990: IL-4 inhibits the expression of high affinity IL-2 receptors on monoclonal human B cells. Journal of Immunology 145(4): 1152-1158

Vercelli, D.; Jabara, H.H.; Lauener, R.P.; Geha, R.S. 1990: IL-4 inhibits the synthesis of IFN-gamma and induces the synthesis of IgE in human mixed lymphocyte cultures. Journal of Immunology 144(2): 570-573

Del Prete, G.; Maggi, E.; Parronchi, P.; Chrétien, I.; Tiri, A.; Macchia, D.; Ricci, M.; Banchereau, J.; De Vries, J.; Romagnani, S. 1988: IL-4 is an essential factor for the IgE synthesis induced in vitro by human T cell clones and their supernatants. Journal of Immunology 140(12): 4193-4198

Ochel, M.; Vohr, H.W.; Pfeiffer, C.; Gleichmann, E. 1991: IL-4 is required for the IgE and IgG1 increase and IgG1 autoantibody formation in mice treated with mercuric chloride. Journal of Immunology 146(9): 3006-3011

Finkelman, F.D.; Katona, I.M.; Urban, J.F.; Holmes, J.; Ohara, J.; Tung, A.S.; Sample, J.V.; Paul, W.E. 1988: IL-4 is required to generate and sustain in vivo IgE responses. Journal of Immunology 141(7): 2335-2341

Abehsira-Amar, O.; Gibert, M.; Joliy, M.; Thèze, J.; Jankovic, D.L. 1992: IL-4 plays a dominant role in the differential development of Tho into Th1 and Th2 cells. Journal of Immunology 148(12): 3820-3829

Miller, C.L.; Hooton, J.W.; Gillis, S.; Paetkau, V. 1990: IL-4 potentiates the IL-2-dependent proliferation of mouse cytotoxic T cells. Journal of Immunology 144(4): 1331-1337

Ben-Sasson, S.Z.; Le Gros, G.; Conrad, D.H.; Finkelman, F.D.; Paul, W.E. 1990: IL-4 production by T cells from naive donors. IL-2 is required for IL-4 production. Journal of Immunology 145(4): 1127-1136

Rao, M.; Conrad, D.H. 1989: IL-4 production by T depleted cells from Nippostrongylus brasiliensis infected mice. Immunological Investigations 18(9-10): 1055-1070

Harnett, M.M.; Holman, M.J.; Klaus, G.G. 1991: IL-4 promotes anti-Ig-mediated protein kinase C translocation and reverses phorbol ester-mediated protein kinase C down-regulation in murine B cells. Journal of Immunology 147(11): 3831-3836

Kawakami, Y.; Custer, M.C.; Rosenberg, S.A.; Lotze, M.T. 1989: IL-4 regulates IL-2 induction of lymphokine-activated killer activity from human lymphocytes. Journal of Immunology 142(10): 3452-3461

Sillaber, C.; Strobl, H.; Bevec, D.; Ashman, L.K.; Butterfield, J.H.; Lechner, K.; Maurer, D.; Bettelheim, P.; Valent, P. 1991: IL-4 regulates c-kit proto-oncogene product expression in human mast and myeloid progenitor cells. Journal of Immunology 147(12): 4224-4228

Hofman, F.M.; Brock, M.; Taylor, C.R.; Lyons, B. 1988: IL-4 regulates differentiation and proliferation of human precursor B cells. Journal of Immunology 141(4): 1185-1190

Thornhill, M.H.; Haskard, D.O. 1990: IL-4 regulates endothelial cell activation by IL-1, tumor necrosis factor, or IFN-gamma. Journal of Immunology 145(3): 865-872

Ting, C.C.; Hargrove, M.E. 1992: IL-4 regulation of a protein kinase C independent pathway for the generation of alpha CD3-induced activated killer cells. Cellular Immunology 140(1): 130-144

Mulé, J.J.; Krosnick, J.A.; Rosenberg, S.A. 1989: IL-4 regulation of murine lymphokine-activated killer activity in vitro. Effects on the IL-2-induced expansion, cytotoxicity, and phenotype of lymphokine-activated killer effectors. Journal of Immunology 142(2): 726-733

Katona, I.M.; Urban, J.F.; Kang, S.S.; Paul, W.E.; Finkelman, F.D. 1991: IL-4 requirements for the generation of secondary in vivo IgE responses. Journal of Immunology 146(12): 4215-4221

Hart, P.H.; Cooper, R.L.; Finlay-Jones, J.J. 1991: IL-4 suppresses IL-1 beta, TNF-alpha and PGE2 production by human peritoneal macrophages. Immunology 72(3): 344-349

Gautam, S.; Tebo, J.M.; Hamilton, T.A. 1992: IL-4 suppresses cytokine gene expression induced by IFN-gamma and/or IL-2 in murine peritoneal macrophages. Journal of Immunology 148(6): 1725-1730

DeKruyff, R.H.; Fang, Y.; Umetsu, D.T. 1992: IL-4 synthesis by in vivo primed keyhole limpet hemocyanin-specific CD4+ T cells. I. Influence of antigen concentration and antigen-presenting cell type. Journal of Immunology 149(11): 3468-3476

Jankovic, D.L.; Abehsira-Amar, O.; Korner, M.; Roth, C.; Hitoshi, Y.; Takatsu, K.; Theze, J. 1988: IL-4, but not IL-5, can act synergistically with B cell activating factor (BCAF) to induce proliferation of resting B cells. Cellular Immunology 117(1): 165-176

Zhang, X.H.; Werner-Favre, C.; Tang, H.Y.; Brouwers, N.; Bonnefoy, J.Y.; Zubler, R.H. 1991: IL-4-dependent IgE switch in membrane IgA-positive human B cells. Journal of Immunology 147(9): 3001-3004

Renz, H.; Domenico, J.; Gelfand, E.W. 1991: IL-4-dependent up-regulation of IL-4 receptor expression in murine T and B cells. Journal of Immunology 146(9): 3049-3055

Berton, M.T.; Vitetta, E.S. 1992: IL-4-induced expression of germline gamma 1 transcripts in B cells following cognate interactions with T helper cells. International Immunology 4(3): 387-396

Peace, D.J.; Kern, D.E.; Schultz, K.R.; Greenberg, P.D.; Cheever, M.A. 1988: IL-4-induced lymphokine-activated killer cells. Lytic activity is mediated by phenotypically distinct natural killer-like and T cell-like large granular lymphocytes. Journal of Immunology 140(10): 3679-3685

Poulsen, L.K.; Katamura, K.; Ishizaka, K. 1991: IL-4-producing murine T helper cell line provides help for in vitro production of IgE. International Archives of Allergy and Applied Immunology 95(4): 363-368

Pawelec, G.P.; Rehbein, A.; Schaudt, K.; Busch, F.W. 1989: IL-4-responsive human helper T cell clones are resistant to growth inhibition by tumor necrosis factor-alpha. Journal of Immunology 143(3): 902-906

Bertagnolli, M.M.; Takai, Y.; Herrmann, S.H. 1991: IL-4-supported induction of cytolytic T lymphocytes requires IL-2 and IL-6. Cellular Immunology 133(2): 327-341

Murakami, S.; Miyake, K.; June, C.H.; Kincade, P.W.; Hodes, R.J. 1990: IL-5 induces a Pgp-1 (CD44) bright B cell subpopulation that is highly enriched in proliferative and Ig secretory activity and binds to hyaluronate. Journal of Immunology 145(11): 3618-3627

Tsiagbe, V.K.; Nicknam, M.H.; Fattah, D.; Thorbecke, G.J. 1992: IL-5 responsive subsets among normal and lymphomatous murine B cells. Annals of the new York Academy of Sciences 651: 270-273

Yoshimoto, T.; Nakanishi, K.; Matsui, K.; Hirose, S.; Hiroishi, K.; Tanaka, T.; Hada, T.; Hamaoka, T.; Higashino, K. 1990: IL-5 up-regulates but IL-4 down-regulates IL-2R expression on a cloned B lymphoma line. Journal of Immunology 144(1): 183-190

Katoh, S.; Takatsu, K. 1992: IL-5-and its receptor--the role of IL-5 in the development of hematopoietic cells in the long-term bone marrow cultures. Nihon Rinsho. Japanese Journal of Clinical Medicine 50(8): 1795-1801

Rothenberg, M.E.; Petersen, J.; Stevens, R.L.; Silberstein, D.S.; McKenzie, D.T.; Austen, K.F.; Owen, W.F. 1989: IL-5-dependent conversion of normodense human eosinophils to the hypodense phenotype uses 3T3 fibroblasts for enhanced viability, accelerated hypodensity, and sustained antibody-dependent cytotoxicity. Journal of Immunology 143(7): 2311-2316

Li, Y.S.; Gimond, C.; Revillard, J.P. 1992: IL-5-induced IgA synthesis by LPS-stimulated mouse B cells is prevented by protein kinase C inhibitors. European Cytokine Network 3(2): 103-107

Goitsuka, R.; Ohashi, T.; Ono, K.; Yasukawa, K.; Koishibara, Y.; Fukui, H.; Ohsugi, Y.; Hasegawa, A. 1990: IL-6 activity in feline infectious peritonitis. Journal of Immunology 144(7): 2599-2603

Ruppert, J.; Peters, J.H. 1991: IL-6 and IL-1 enhance the accessory activity of human blood monocytes during differentiation to macrophages. Journal of Immunology 146(1): 144-149

Holsti, M.A.; Raulet, D.H. 1989: IL-6 and IL-1 synergize to stimulate IL-2 production and proliferation of peripheral T cells. Journal of Immunology 143(8): 2514-2519

Murakami, M.; Hirano, T. 1990: IL-6 and IL-6 receptor. Seikagaku. Journal of Japanese Biochemical Society 62(1): 32-35

Sanceau, J.; Wijdenes, J.; Revel, M.; Wietzerbin, J. 1991: IL-6 and IL-6 receptor modulation by IFN-gamma and tumor necrosis factor-alpha in human monocytic cell line (THP-1). Priming effect of IFN-gamma. Journal of Immunology 147(8): 2630-2637

Akira, S.; Kishimoto, T. 1992: IL-6 and NF-IL6 in acute-phase response and viral infection. Immunological Reviews 127: 25-50

Deviere, J.; Content, J.; Crusiaux, A.; Dupont, E. 1991: IL-6 and TNF alpha in ascitic fluid during spontaneous bacterial peritonitis. Digestive Diseases and Sciences 36(1): 123-124

Watson, J.; Crilly, A.; Madhok, R.; Capell, H.; Sturrock, R. 1992: IL-6 and soluble IL-2 receptor in rheumatoid arthritis patients treated with second line drugs. Biochemical Society Transactions 20(2): 138s

Rieckmann, P.; D'Alessandro, F.; Nordan, R.P.; Fauci, A.S.; Kehrl, J.H. 1991: IL-6 and tumor necrosis factor-alpha. Autocrine and paracrine cytokines involved in B cell function. Journal of Immunology 146(10): 3462-3468

Nilsson, K.; Jernberg, H.; Pettersson, M. 1990: IL-6 as a growth factor for human multiple myeloma cells--a short overview. Current Topics in Microbiology and Immunology 166: 3-12

Tsan, M.F.; White, J.E.; Del Vecchio, P.J.; Shaffer, J.B. 1992: IL-6 enhances TNF-alpha- and IL-1-induced increase of Mn superoxide dismutase mRNA and O2 tolerance. American Journal of Physiology 263(1 Part 1): L22-L26

Iho, S.; Shau, H.; Golub, S.H. 1992: IL-6 enhances the cytotoxic activity of thymocyte-derived CD56+ cells. Cellular Immunology 144(1): 1-10

Ming, J.E.; Steinman, R.M.; Granelli-Piperno, A. 1992: IL-6 enhances the generation of cytolytic T lymphocytes in the allogeneic mixed leucocyte reaction. Clinical and Experimental Immunology 89(1): 148-153

Gauldie, J.; Northemann, W.; Fey, G.H. 1990: IL-6 functions as an exocrine hormone in inflammation. Hepatocytes undergoing acute phase responses require exogenous IL-6. Journal of Immunology 144(10): 3804-3808

Fugger, L.; Morling, N.; Bendtzen, K.; Ryder, L.; Andersen, V.; Heilman, C.; Karup Pedersen, F.; Friis, J.; Halbert, P.; Svejgaard, A. 1989: IL-6 gene polymorphism in rheumatoid arthritis, pauciarticular juvenile rheumatoid arthritis, systemic lupus erythematosus, and in healthy Danes. Journal of Immunogenetics 16(6): 461-465

Yanagawa, H.; Sone, S.; Munekata, M.; Atagi, S.; Nii, A.; Ogura, T. 1992: IL-6 in malignant pleural effusions and its augmentation by intrapleural instillation of IL-2. Clinical and Experimental Immunology 88(2): 207-212

Hovdenes, J.; Kvien, T.K.; Hovdenes, A.B. 1990: IL-6 in synovial fluids, plasma and supernatants from cultured cells of patients with rheumatoid arthritis and other inflammatory arthritides. Scandinavian Journal of Rheumatology 19(3): 177-182

Maruo, N.; Morita, I.; Shirao, M.; Murota, S. 1992: IL-6 increases endothelial permeability in vitro. Endocrinology 131(2): 710-714

Pied, S.; Civas, A.; Berlot-Picard, F.; Renia, L.; Miltgen, F.; Gentilini, M.; Doly, J.; Mazier, D. 1992: IL-6 induced by IL-1 inhibits malaria pre-erythrocytic stages but its secretion is down-regulated by the parasite. Journal of Immunology 148(1): 197-201

Nakajima, K.; Wall, R. 1990: IL-6 induces hybridoma cell growth through a novel signalling pathway. Current Topics in Microbiology and Immunology 166: 51-61

Aderka, D.; Le, J.M.; Vilcek, J. 1989: IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice. Journal of Immunology 143(11): 3517-3523

Chiu, C.P.; Lee, F. 1989: IL-6 is a differentiation factor for M1 and WEHI-3B myeloid leukemic cells. Journal of Immunology 142(6): 1909-1915

Kunimoto, D.Y.; Nordan, R.P.; Strober, W. 1989: IL-6 is a potent cofactor of IL-1 in IgM synthesis and of IL-5 in IgA synthesis. Journal of Immunology 143(7): 2230-2235

Lorré, K.; Van Damme, J.; Verwilghen, J.; Baroja, M.L.; Ceuppens, J.L. 1990: IL-6 is an accessory signal in the alternative CD2-mediated pathway of T cell activation. Journal of Immunology 144(12): 4681-4687

Helle, M.; Boeije, L.; Aarden, L.A. 1989: IL-6 is an intermediate in IL-1-induced thymocyte proliferation. Journal of Immunology 142(12): 4335-4338

Ishimi, Y.; Miyaura, C.; Jin, C.H.; Akatsu, T.; Abe, E.; Nakamura, Y.; Yamaguchi, A.; Yoshiki, S.; Matsuda, T.; Hirano, T. 1990: IL-6 is produced by osteoblasts and induces bone resorption. Journal of Immunology 145(10): 3297-3303

Nawata, Y.; Eugui, E.M.; Lee, S.W.; Allison, A.C. 1989: IL-6 is the principal factor produced by synovia of patients with rheumatoid arthritis that induces B-lymphocytes to secrete immunoglobulins. Annals of the new York Academy of Sciences 557: 230-8; Discussion 239

Diebold, S.; Peuchmaur, M.; Emilie, D.; Crevon, M.C.; Solal-Celigny, P.; Tertian, G.; Galanaud, P. 1992: IL-6 mRNA expression in CD25 positive malignant lymphomas. European Cytokine Network 3(3): 313-319

Marinkovic, S.; Jahreis, G.P.; Wong, G.G.; Baumann, H. 1989: IL-6 modulates the synthesis of a specific set of acute phase plasma proteins in vivo. Journal of Immunology 142(3): 808-812

Villiger, P.M.; Cronin, M.T.; Amenomori, T.; Wachsman, W.; Lotz, M. 1991: IL-6 production by human T lymphocytes. Expression in HTLV-1-infected but not in normal T cells. Journal of Immunology 146(2): 550-559

Guerne, P.A.; Carson, D.A.; Lotz, M. 1990: IL-6 production by human articular chondrocytes. Modulation of its synthesis by cytokines, growth factors, and hormones in vitro. Journal of Immunology 144(2): 499-505

Einerhand, M.P.; Bakx, T.A.; Valerio, D. 1991: IL-6 production by retrovirus packaging cells and cultured bone marrow cells. Human Gene Therapy 2(4): 301-306

Kishimoto, T.; Akira, S.; Taga, T. 1992: IL-6 receptor and mechanism of signal transduction. International Journal of Immunopharmacology 14(3): 431-438

Nakajima, K.; Hirano, T. 1991: IL-6 receptor and signal transduction pathway. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 36(4): 687-695

Chen, L.; Shulman, L.M.; Revel, M. 1991: IL-6 receptors and sensitivity to growth inhibition by IL-6 in clones of human breast carcinoma cells. Journal of Biological Regulators and Homeostatic Agents 5(4): 125-136

Kurihara, N.; Bertolini, D.; Suda, T.; Akiyama, Y.; Roodman, G.D. 1990: IL-6 stimulates osteoclast-like multinucleated cell formation in long term human marrow cultures by inducing IL-1 release. Journal of Immunology 144(11): 4226-4230

Bauer, J.; Strauss, S.; Volk, B.; Berger, M. 1991: IL-6-mediated events in Alzheimer's disease pathology. Immunology Today 12(11): 422

Tamm, I. 1989: IL-6. Current research and new questions. Annals of the new York Academy of Sciences 557: 478-489

Okada, M.; Kitahara, M.; Kishimoto, S.; Matsuda, T.; Hirano, T.; Kishimoto, T. 1988: IL-6/BSF-2 functions as a killer helper factor in the in vitro induction of cytotoxic T cells. Journal of Immunology 141(5): 1543-1549

Bulgarini, D.; Scalzo, S.; Boccoli, G.; Petrini, M.; Quaranta, M.T.; Camagna, A.; Isacchi, G.; Testa, U.; Peschle, C. 1991: IL-6/BSF-2 selectively stimulates the GO----S progression of CD8+ lymphocytes. Journal of Biological Regulators and Homeostatic Agents 5(1): 23-33

Matsuda, T.; Suematsu, S.; Kawano, M.; Yoshizaki, K.; Tang, B.; Tanabe, O.; Nakajima, T.; Akira, S.; Hirano, T.; Kishimoto, T. 1989: IL-6/BSF2 in normal and abnormal regulation of immune responses. Annals of the new York Academy of Sciences 557: 466-476; Discussion: 476-477

Bhardwaj, N.; Santhanam, U.; Lau, L.L.; Tatter, S.B.; Ghrayeb, J.; Rivelis, M.; Steinman, R.M.; Sehgal, P.B.; May, L.T. 1989: IL-6/IFN-beta 2 in synovial effusions of patients with rheumatoid arthritis and other arthritides. Identification of several isoforms and studies of cellular sources. Journal of Immunology 143(7): 2153-2159

Jablons, D.M.; Mulé, J.J.; McIntosh, J.K.; Sehgal, P.B.; May, L.T.; Huang, C.M.; Rosenberg, S.A.; Lotze, M.T. 1989: IL-6/IFN-beta-2 as a circulating hormone. Induction by cytokine administration in humans. Journal of Immunology 142(5): 1542-1547

Paul, W. 1991: IL-6: a multifunctional regulator of immunity and inflammation. Japanese Journal of Cancer Research: Gann 82(12): 1458-1459

Poli, V.; Mancini, F.P.; Cortese, R. 1990: IL-6DBP, a nuclear protein involved in interleukin-6 signal transduction, defines a new family of leucine zipper proteins related to C/EBP. Cell 63(3): 643-653

Stötter, H.; Custer, M.C.; Bolton, E.S.; Guedez, L.; Lotze, M.T. 1991: IL-7 induces human lymphokine-activated killer cell activity and is regulated by IL-4. Journal of Immunology 146(1): 150-155

Fabbi, M.; Groh, V.; Strominger, J.L. 1992: IL-7 induces proliferation of CD3-/low CD4- CD8- human thymocyte precursors by an IL-2 independent pathway. International Immunology 4(1): 1-5

Murray, R.; Suda, T.; Wrighton, N.; Lee, F.; Zlotnik, A. 1989: IL-7 is a growth and maintenance factor for mature and immature thymocyte subsets. International Immunology 1(5): 526-531

Herbelin, A.; Machavoine, F.; Schneider, E.; Papiernik, M.; Dy, M. 1992: IL-7 is requisite for IL-1-induced thymocyte proliferation. Involvement of IL-7 in the synergistic effects of granulocyte-macrophage colony-stimulating factor or tumor necrosis factor with IL-1. Journal of Immunology 148(1): 99-105

Okazaki, H.; Ito, M.; Sudo, T.; Hattori, M.; Kano, S.; Katsura, Y.; Minato, N. 1989: IL-7 promotes thymocyte proliferation and maintains immunocompetent thymocytes bearing alpha beta or gamma delta T-cell receptors in vitro: synergism with IL-2. Journal of Immunology 143(9): 2917-2922

Roifman, C.M.; Wang, G.X.; Freedman, M.; Pan, Z.Q. 1992: IL-7 receptor mediates tyrosine phosphorylation but does not activate the phosphatidylinositol-phospholipase C-gamma 1 pathway. Journal of Immunology 148(4): 1136-1142

Bertagnolli, M.; Herrmann, S. 1990: IL-7 supports the generation of cytotoxic T lymphocytes from thymocytes. Multiple lymphokines required for proliferation and cytotoxicity. Journal of Immunology 145(6): 1706-1712

Standiford, T.J.; Strieter, R.M.; Allen, R.M.; Burdick, M.D.; Kunkel, S.L. 1992: IL-7 up-regulates the expression of IL-8 from resting and stimulated human blood monocytes. Journal of Immunology 149(6): 2035-2039

Sheron, N.; Williams, R. 1992: IL-8 as a circulating cytokine: induction by recombinant tumour necrosis factor-alpha. Clinical and Experimental Immunology 89(1): 100-103

Ribeiro, R.A.; Flores, C.A.; Cunha, F.Q.; Ferreira, S.H. 1991: IL-8 causes in vivo neutrophil migration by a cell-dependent mechanism. Immunology 73(4): 472-477

Smyth, M.J.; Zachariae, C.O.; Norihisa, Y.; Ortaldo, J.R.; Hishinuma, A.; Matsushima, K. 1991: IL-8 gene expression and production in human peripheral blood lymphocyte subsets. Journal of Immunology 146(11): 3815-3823

Van Zee, K.J.; DeForge, L.E.; Fischer, E.; Marano, M.A.; Kenney, J.S.; Remick, D.G.; Lowry, S.F.; Moldawer, L.L. 1991: IL-8 in septic shock, endotoxemia, and after IL-1 administration. Journal of Immunology 146(10): 3478-3482

Kuna, P.; Reddigari, S.R.; Kornfeld, D.; Kaplan, A.P. 1991: IL-8 inhibits histamine release from human basophils induced by histamine-releasing factors, connective tissue activating peptide III, and IL-3. Journal of Immunology 147(6): 1920-1924

Pike, M.C.; Costello, K.M.; Lamb, K.A. 1992: IL-8 stimulates phosphatidylinositol-4-phosphate kinase in human polymorphonuclear leukocytes. Journal of Immunology 148(10): 3158-3164

Kasahara, T.; Yagisawa, H.; Yamashita, K.; Yamaguchi, Y.; Akiyama, Y. 1990: IL1 induces proliferation and IL6 mRNA expression in a human astrocytoma cell line: positive and negative modulation by chorela toxin and cAMP. Biochemical and Biophysical Research Communications 167(3): 1242-1248

Demczuk, S. 1988: IL1/ETAF activity and undetectable IL1 beta mRNA and minimal IL1 alpha mRNA levels in normal adult heat-separated epidermis. Biochemical and Biophysical Research Communications 156(1): 463-469

Sakiyama, Y.; Takahashi, Y.; Matsumoto, S. 1987: IL2 production and IL2 receptor expression in primary immunodeficiency diseases. Acta Paediatrica Japonica: Overseas Edition 29(5): 678-679

Bruserud, O.; Hamann, W.; Patel, S.; Ehninger, G.; Pawelec, G. 1992: IL2- and IL4-dependent proliferation of T-cell clones derived early after allogeneic bone marrow transplantation: studies of patients with chronic myelogenous leukaemia. European Journal of Haematology 48(4): 221-227

Lorberboum-Galski, H.; Garsia, R.J.; Gately, M.; Brown, P.S.; Clark, R.E.; Waldmann, T.A.; Chaudhary, V.K.; FitzGerald, D.J.; Pastan, I. 1990: IL2-PE664Glu, a new chimeric protein cytotoxic to human-activated T lymphocytes. Journal of Biological Chemistry 265(27): 16311-16317

Soubiran, P.; Zapitelli, J.P.; Schaffar, L. 1987: IL2-like material is present in human placenta and amnion. Journal of Reproductive Immunology 12(3): 225-234

Crompton, T. 1991: IL3-dependent cells die by apoptosis on removal of their growth factor. Growth Factors 4(2): 109-116

Lindsberg, M.L.; Brunswick, M.; Keegan, A.; Mond, J.J. 1990: IL4 is not required for proliferative responses in B cells stimulated by anti-IgD-dextran conjugates even under limiting conditions of cell-cell interaction. Cellular Immunology 130(2): 320-328

Kawanishi, H.; Joseph, K. 1991: IL4, IL5 and IL6-mediated regulation of immunoglobulin (Ig) heavy chain class switching and Ig production by gut-associated lymphoid tissue (GALT) B cells from athymic nude (nu/nu) mice. Immunological Investigations 20(7): 605-621

Mock, B.A.; Krall, M.; Kozak, C.A.; Nesbitt, M.N.; McBride, O.W.; Renauld, J.C.; Van Snick, J. 1990: IL9 maps to mouse chromosome 13 and human chromosome 5. Immunogenetics 31(4): 265-270

Shuto, H.; Nakagami, K.; Suzuki, H.; Noguchi, E. 1986: ILF (interferential low frequency) therapy of patients with bronchial asthma. Arerugi 35(12): 1170-1180

Umetani, S. 1977: ILO Convention--its significance and its limitations. Japanese Journal of Nursing 29(10): 30-38

Kojima, Y. 1977: ILO adoptation of the standard labor conditions of nursing and the future prospects. Kangogaku Zasshi 41(11): 1132-1134

Lloyd, P. 1977: ILO charter of justice for nurses. Occupational Health; a Journal for Occupational Health Nurses 29(10): 440-443

Antonsen, K. 1985: ILO conference: Norway oil wants reduction in occupational health services. Sykepleien 72(16): 18-19

Anonymous 1977: ILO conventions determine quality of health care throughout the world. Vardfacket 1(20): 63-64

Kuboniwa, K. 1979: ILO pages: questioning, again, how professional organizations ought to be. Japanese Journal of Nursing 31(8): 114-119

Sato, T. 1979: ILO pages: what we got out of the symposium "Observations on medical care among us all" and future problems in organization. Japanese Journal of Nursing 31(11): 83-88

Saunders, A. 1976: Modern antihypertensive therapy. Part i. Australian Nurses' Journal. Royal Australian Nursing Federation 6(1): 29

Hodous, T.K. 1990: ILO "A" and "B" reader classification. Journal of Occupational Medicine.: Official Publication of the Industrial Medical Association 32(3): 267

Abe, M. 1977: Psychological processes of the aged. 8. Japanese Journal of Nursing 29(8): 139-144

Nousiainen, T. 1976: ILO's deliberations on nursing personnel's working conditions. Sairaanhoitaja. Sjukskoterskan 1976(16): 11-13

Nousiainen, T. 1977: ILO's employment conditions agreement and recommendations in the health care field. Sairaanhoitaja. Sjukskoterskan 53(16): 6-7

Anonymous 1977: ILO's message to health care personnel. Sairaanhoitaja. Sjukskoterskan 53(13-14): 3-4

Anonymous 1985: ILO-OIT: the growing and changing world of health care. Nouvelles - Comite international catholique des infirmieres et assistantes medico-sociales. News - International Committee of Catholic Nurses and Medico-Social Workers 1985(3): 24-29

Anonymous 1991: ILO: lessening the risks of HIV for nursing personnel. International Nursing Review 38(1): 7

Kiraly, J.K. 1991: Magnesium should not be omitted when managing seizures in pregnancy. Annals of Emergency Medicine 20(11): 1277

Okabe, T.; Isono, F.; Kashiwagi, M.; Takahashi, M.; Nishimura, T.; Suzuki, H.; Tanaka, N. 1985: IM8443T substance, an antitumor triene beta-lactone antibiotic. Journal of Antibiotics 38(7): 964-965

Majumdar, J. 1975: IMA Chief speaks at the 29th W.M. Assembly. Journal of the Indian Medical Association 65(8): 242-244

Nava, L.C. 1985: IMA Ii brace for deambulatory treatment of Legg-Perthes disease. Journal of Biomedical Engineering 7(1): 71-74

Colbert, D.S.; Chater, E.H. 1975: Dislocation of the proximal tibiofibular joint after minor injury. Irish Medical Journal 68(1): 13-17

Anonymous 1978: IMA marches on the golden jubilee year. Journal of the Indian Medical Association 71(6): 155-156

Anonymous 1975: IMA maternal mortality report 1974. Irish Medical Journal 68(22): 559-563

McQuaid, P.E. 1977: Some aspects of family violence as it affects young children. Irish Medical Journal 70(19): 569-573

Idbeis, B.; Yacoubian, V.S.; Lewis, H.M. 1986: IMA--a preferred conduit. Kansas Medicine: the Journal of the Kansas Medical Society 87(4): 98; 117

Mohr, F.W.; Falk, V.; Krieger, H.; Likungu, J.; Abu Aisha, N.; Coppola, R.; Diegeler, A.; Matloff, J.; Kirchhoff, P.G. 1991: IMA-graft patency control by thermal coronary angiography during coronary bypass surgery. European Journal of Cardio-Thoracic Surgery: Official Journal of the European Association for Cardio-Thoracic Surgery 5(10): 534-541

Diaspro, A.; Adami, M.; Sartore, M.; Nicolini, C. 1990: IMAGO: a complete system for acquisition, processing, two/three-dimensional and temporal display of microscopic bio-images. Computer Methods and Programs in Biomedicine 31(3-4): 225-236

Grover, N.K. 1990: IMC Act (Amendment) Bill 1989: IMA opposes retrograde steps. Journal of the Indian Medical Association 88(5): 124-125

Braile, D.M.; Ardito, R.V.; Greco, O.T.; Lorga, A.M. 1991: IMC bovine pericardial valve: 11 years. Journal of Cardiac Surgery 6(4 Suppl): 580-588

Traska, M.R. 1987: IMC goes belly-up; state still seeks potential buyers. Hospitals 61(12): 64; 66

Firshein, J. 1986: IMC trouble may influence HCFA Medicare ruling. Hospitals 60(13): 87-88

Cembrzyńska-Nowak, M. 1979: IME -- an inhibitor of interferon activity isolated from mouse embryonic tissues. II. Biological characteristics. Archivum Immunologiae et Therapiae Experimentalis 27(1-2): 229-239

Kassir, Y.; Granot, D.; Simchen, G. 1988: IME1, a positive regulator gene of meiosis in S. cerevisiae. Cell 52(6): 853-862

Zeulzer, W.W.; Ravindranath, Y.; Lusher, J.M.; Sarnaik, S.; Considine, B. 1976: IMFRA (intermittent intrathecal methotrexate and fractional radiation) plus chemotherapy in childhood leukemia. American Journal of Hematology 1(2): 191-199

Kozakiewicz, Z. 1992: IMi descriptions of fungi and bacteria no. 1101. Penicillium aurantiogriseum. Mycopathologia 117(3): 165-166

Kozakiewicz, Z. 1992: IMI descriptions of fungi and bacteria no. 1103. Penicillium camembertii. Mycopathologia 117(3): 169-170

Kozakiewicz, Z. 1992: IMi descriptions of fungi and bacteria no. 1104. Penicillium citrinum. Mycopathologia 117(3): 171-172

Kozakiewicz, Z. 1992: IMi descriptions of fungi and bacteria no. 1105. Penicillium glabrum. Mycopathologia 117(3): 173-174

Kozakiewicz, Z. 1992: IMi descriptions of fungi and bacteria no. 1106. Penicillium islandicum. Mycopathologia 117(3): 175-176

Kozakiewicz, Z. 1992: IMi descriptions of fungi and bacteria no. 1107. Penicillium oxalicum. Mycopathologia 117(3): 177-178

Kozakiewicz, Z. 1992: IMi descriptions of fungi and bacteria no. 1108. Penicillium purpurogenum. Mycopathologia 117(3): 179-180

Kozakiewicz, Z. 1992: IMi descriptions of fungi and bacteria no. 1109. Penicillium roquefortii. Mycopathologia 117(3): 181-182

Kozakiewicz, Z. 1992: IMi descriptions of fungi and bacteria no. 1110. Penicillium viridicatum. Mycopathologia 117(3): 183-184

Palmer, S.E.; Passmore, J.L. 1987: Midline scrotal ablation technique for unilateral cryptorchid castration in horses. Journal of the American Veterinary Medical Association 190(3): 283-285

Dave, H.P. 1986: Topical anti-infective eye preparations. Medical Laboratory Sciences 43(4): 398

Weber, G. 1991: IMP dehydrogenase and GTP as targets in human leukemia treatment. Advances in Experimental Medicine and Biology 309b: 287-292

Yamada, Y.; Goto, H.; Yoshino, M.; Ogasawara, N. 1990: IMP dehydrogenase and action of antimetabolites in human cultured blast cells. Biochimica et Biophysica Acta 1051(3): 209-214

Yamada, Y.; Natsumeda, Y.; Yamaji, Y.; Jayaram, H.N.; Tricot, G.J.; Hoffman, R.; Weber, G. 1989: IMP dehydrogenase: inhibition by the anti-leukemic drug, tiazofurin. Leukemia Research 13(2): 179-184

Hohl, C.M.; Wimsatt, D.K.; Brierley, G.P.; Altschuld, R.A. 1989: IMP production by ATP-depleted adult rat heart cells. Effects of glycolysis and alpha 1-adrenergic stimulation. Circulation Research 65(3): 754-760

Carvalho Júnior, L.B.; Oliveira, E.A.; Silva, M.P.; Accioly, L.G. 1988: IMP synthesis using immobilized adenosine (phosphate) deaminase. Applied Biochemistry and Biotechnology 19(1): 21-25

Geiger, R.; Guglielmi, H. 1975: IMP-cyclohydrolase/transformylase from ehrlich-ascites carcinoma. Hoppe-Seyler's Zeitschrift für Physiologische Chemie 356(6): 819-825

Woolley, P.O.; Woolley, B.A. 1976: IMP: a new method for health problem assessment. Journal of Community Health 2(2): 107-112

Räsänen, J. 1992: IMPRV--synchronized APRV, or more?. Intensive Care Medicine 18(2): 65-66

Naeymi-Rad, F.; Almeida, F.D.; Trace, D. 1992: IMR-entry (Intelligent Medical Record-Entry). Proceedings. Symposium on Computer Applications in Medical Care 1992: 783-784

Jacobo, E.; Culp, D.A. 1977: Advanced prostatic cancer revisited--35 years later. Journal of the Iowa Medical Society 67(2): 52-55

Benson, P.; Hesson, W.; Moser, C. 1992: IMS, ISBA cooperation yields new laws on advance directives. Iowa Medicine: Journal of the Iowa Medical Society 82(1): 13-14

Page, B.A.; Downs, J.B. 1977: IMV and continuous gas flow--a complication. Anesthesiology 46(1): 72-73

Kacmarek, R.M.; Wilson, R.S. 1985: IMV systems. do they make a difference?. Chest 87(5): 557

Stroup, D.; Temo, J. 1978: IMV: updated. Aana Journal 46(4): 384-388

Huijgens, P.C.; Ossenkoppele, G.J.; Van Der Lelie, J.; Thomas, L.L.; Wijngaarden, M.J.; Slaper, C.M. 1991: IMVP-16 followed by high dose chemotherapy and autologous bone marrow transplantation as salvage treatment for malignant lymphoma. Hematological Oncology 9(4-5): 245-251

Novaes, A.B.; Novaes, A.B. 1992: IMZ implants placed into extraction sockets in association with membrane therapy (Gengiflex) and porous hydroxyapatite: a case report. International Journal of Oral and Maxillofacial Implants 7(4): 536-540

Mentag, P.J.; Kosinski, T.F.; Sowinski, L.L. 1988: IMZ overdenture construction using the Stern ERA attachment. General Dentistry 36(5): 390-392

Horecký, J.; Brozman, B.; Babusiková, F.; Barta, E.; Gleso, L. 1977: IMicrocirculatory and functional changes in the kidneys in acute hypervolemic hemodilution. Rozhledy V Chirurgii: Mesicnik Ceskoslovenske Chirurgicke Spolecnosti 56(4): 285-290

Zhang, H.X. 1986: Postoperative care of patients with pheochromocytoma of the bladder. Zhonghua Hu Li Za Zhi 21(1): 24-25

Eschen, M. 1988: INA report on RCTs. Rn Idaho 11(5): 3

Kelley, C. 1978: INA-AJN Writing Award 1978. Flashback: psychiatry. Chart 75(10): 2-3

Shine, E.; Frerichs, M. 1976: INA-CERP: the review process. Journal of Continuing Education in Nursing 7(1): 40-43

Ardón, E. 1989: INCAP'S policies and strategies for training and capacitation of human resources in food and nutrition. Archivos Latinoamericanos de Nutricion 39(3): 357-364

de Palma, V.M.; Delgado, H.; Fischer, M. 1991: INCAP: update of medical knowledge using long distance educational techniques. Educacion Medica y Salud 25(3): 315-324

Lebed, J.P.; Wapner, P.M.; Auerbach, R.S.; Mall, A.K.; Farber, M. 1985: INCO needle paraurethral suspension for stress urinary incontinence. Journal of the American Osteopathic Association 85(5): 314-317

Buchheim, W. 1977: Cryofixation of tissue without cryoprotectants. Die Naturwissenschaften 64(5): 270

Guy-Grand, B. 1992: INDEX (international dexfenfluramine study) as a model for long-term pharmacotherapy of obesity in the 1990s. International Journal of Obesity and Related Metabolic Disorders: Journal of the International Association for the Study of Obesity 16 Suppl. 3: S5-14

Danhauer, J.L.; Appel, M.A. 1976: INDSCAL analysis of perceptual judgments for 24 consonants via visual, tactile, and visual-tactile inputs. Journal of Speech and Hearing Research 19(1): 68-77

Rantanen, T. 1989: INFODERM--a microcomputer database system with Finnish product files. Seminars in Dermatology 8(2): 94-95

Ambroso, C.; Bowes, C.; Chambrin, M.C.; Gilhooly, K.; Green, C.; Kari, A.; Logie, R.; Marraro, G.; Mereu, M.; Rembold, P. 1992: INFORM: European survey of computers in intensive care units. International Journal of Clinical Monitoring and Computing 9(1): 53-61

Bowes, C.L.; Ambroso, C.; Carson, E.R.; Chambrin, M.C.; Cramp, D.; Gilhooly, K.; Groth, T.; Hunter, J.R.; Kalli, S.; Leaning, M.L. 1991: INFORM: development of information management and decision support systems for High Dependency Environments. International Journal of Clinical Monitoring and Computing 8(4): 295-301

Hunter, J.; Chambrin, M.C.; Collinson, P.; Groth, T.; Hedlund, A.; Kalli, S.; Kari, A.; Lenoudias, G.; Ravaux, P.; Ross, D. 1991: INFORM: integrated support for decisions and activities in intensive care. International Journal of Clinical Monitoring and Computing 8(3): 189-199

Peltier, G.; Frey, N.; Legrand, M.; Teyssier, L. 1977: INH and rifampicin dosage at the beginning of tuberculosis treatment. La Nouvelle Presse Medicale 6(30): 2692

Smith, D.B. 1979: INH therapy: benefits versus risks. Neurology 29(10): 1437-1438

Lee, T.H.; Solomon, M.J.; Mumby, M.C.; Kirschner, M.W. 1991: INH, a negative regulator of MPF, is a form of protein phosphatase 2A. Cell 64(2): 415-423

Pavlov, V.G.; Kashaev, V.V.; Protserova, O.K. 1979: INMB-1 neuromuscular block indicator. Meditsinskaia Tekhnika 4: 47-49

Butler, B. 1986: INO Nursing Association for the Elderly. World of Irish Nursing 15(3): 9

Ziegler, V.; Ziegler, B.; Richter, C.; Haustein, U.F. 1990: INPRET (INformation on PREdictive Tests). a data bank on the allergenic potential of industrial and environmental agents. Dermatologische Monatschrift 176(7): 429-430

Ziegler, V.; Richter, C.; Ziegler, B.; Haustein, U.F. 1989: INPRET--database on predictive tests (allergy). Seminars in Dermatology 8(2): 80-82

Urquhart, J. 1985: INPUT pledge drive: dollars = political clout. Michigan Nurse 58(5): 1

Barlow, J.F. 1992: INR and ISI--a step forward!. South Dakota Journal of Medicine 45(11): 313

Poller, L. 1987: INR--calibration of the therapeutic range. Advances in Experimental Medicine and Biology 214: 95-112

van den Besselaar, A.M.; Broekmans, A.W.; Loeliger, E.A. 1986: INR: an internationally accepted standard for the monitoring of oral anticoagulant treatment. Nederlands Tijdschrift Voor Geneeskunde 130(44): 1975-1976

Rutherford, C. 1992: INS position statement. Administration of antineoplastic agents. Journal of intravenous nursing: the official publication of the Intravenous Nurses Society 15(1): 8-9

Loría, A. 1987: INS quality control program. IV. Effect of using standards from a single source in imprecise or inexact systems. Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 39(4): 385-389

Loría, A. 1988: INS quality control program. V. Use of an internal/external program strategy. Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 40(3): 317-323

Herrero López, M.; Cuello Rubio, J. 1986: INSALUD's contribution to the education of nursing personnel. Revista de Enfermeria 9(91): 64-76

De Mazancourt, A.; Waxham, M.N.; Nicolas, J.C.; Wolinsky, J.S. 1986: Antibody response to the rubella virus structural proteins in infants with the congenital rubella syndrome. Journal of Medical Virology 19(2): 111-122

Blibech, A.; Mrad, A.; Belhas, A.; M'Henni, A.; Kastally, R.; Galacteros, F.; Riou, J.; Rosa, J. 1986: Abnormal hemoglobins screened in Tunisia. Nouvelle Revue Francaise d'Hematologie 28(4): 223-225

Lassner, J. 1985: INSERM survey on anesthesia and anesthetist manpower in France. Cahiers d'Anesthesiologie 33(8): 719

Clavel-Chapelon, F. 1992: INSERM-MGEN study. Pathologie-Biologie 39(9): 888-889

Karson, S.G. 1990: INSURE Project report. Transactions of the Association of Life Insurance Medical Directors of America 73: 202-207

Sahlin, P.; Mark, J.; Stenman, G. 1992: INT1 and GLi genes are not rearranged or amplified in benign pleomorphic adenomas with chromosome abnormalities of 12q13-15. Cancer Genetics and Cytogenetics 58(1): 85-88

Rausch, J.L.; Monteiro, M.G.; Schuckit, M.A. 1991: Platelet serotonin uptake in men with family histories of alcoholism. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 4(2): 83-86

Walder, B. 1988: Almost like home. KRANKENPFLEGE. Soins Infirmiers 81(10): 10-15

Masarie, F.E.; Miller, R.A.; Myers, J.D. 1985: INTERNIST-i properties: representing common sense and good medical practice in a computerized medical knowledge base. Computers and Biomedical Research An International Journal 18(5): 458-479

Storkus, W.J.; Howell, D.N.; Salter, R.D.; Dawson, J.R.; Cresswell, P. 1987: NK susceptibility varies inversely with target cell class i HLA antigen expression. Journal of Immunology 138(6): 1657-1659

Farinaro, E.; Trevisan, M.; Jossa, F.; Panico, S.; Celentano, E.; Mancini, M.; Zamboni, S.; Dal Palú, C.; Angelico, F.; Del Ben, M. 1991: INTERSALT in Italy: findings and community health implications. Journal of Human Hypertension 5(1): 15-19

Valentine, J.L.; Hunter, S. 1985: INTRAV and ORAL: BASIC interactive computer programs for estimating pharmacokinetic parameters. Journal of Pharmaceutical Sciences 74(2): 113-119

Spiegel, R.J. 1985: INTRON a (interferon alfa-2b): clinical overview. Cancer Treatment Reviews 12 Suppl B: 5-16

Huret, J.L.; Brizard, A.; Guilhot, F.; Couet, D.; Schoenwald, M.; Savage, J.R.; Tanzer, J. 1990: INV(12) (p13q11) and dicentric chromosomes in a secondary leukaemia with basophilia. Haematologica 75(5): 473-476

Manning, G. 1991: INVEST: a plan for developing new managers. Nursing Management 22(12): 26-28

Mészáros, K.; Mandl, J.; Antoni, F.; Garzó, T. 1976: INhibition of protein synthesis by hexosamine containing glycogen formed in mouse liver after treatment with D-galactosamine. Febs Letters 71(2): 215-219

Wright, E.D.; Slack, C.; Goldfarb, P.S.; Subak-Sharpe, J.H. 1976: INvestigation of the basis of reduced metabolic cooperation in mec- cells. Experimental Cell Research 103(1): 79-91

Huber, A.; Geiger, F.; Schweizer, W.; Baer, H.U.; Triller, K.J.; Blumgart, L.H. 1990: IODIDA scanning for functional and morphologic assessment of the liver and bile ducts before and following surgical interventions in bile duct obstruction. Helvetica Chirurgica Acta 57(1): 7-12

de Dombal, F.T.; Softley, A. 1987: IOIBD report no 1: Observer variation in calculating indices of severity and activity in Crohn's disease. International Organisation for the Study of Inflammatory Bowel Disease. Gut 28(4): 474-481

Bastian, G.O.; Hiss, P. 1992: IOL and aniseikonia calculation combined with documentation of surgical data and IOL inventory. Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 89(4): 352-358

Kalvin, N.H. 1979: IOL design. Journal - American Intra-Ocular Implant Society 5(1): 41-42

Kaye, G.; Laifer, N.; Traykovski, C. 1985: IOL implant patients need your help. Journal of Ophthalmic Nursing and Technology 4(4): 18-23

Li, Z.Q. 1990: IOL implantation for the traumatic cataract. Chinese Journal of Ophthalmology 26(6): 332-334

Gills, J.P.; Loyd, T.L. 1989: IOL power calculation. Ophthalmic Surgery 20(2): 143

Sheingorn, L. 1988: IOL power calculator. Clao Journal: Official Publication of the Contact Lens Association of Ophthalmologists Inc 14(4): 174

Ahmed, M.; Nasthi, A.R. 1987: IOL power determination by retinoscope. Indian Journal of Ophthalmology 35(5-6): 239-241

Prior, C.; Ramsay, R.J.; O'Day, J.; Stephens, R. 1988: IOL prediction: an evaluation of preoperatively determined intraocular lens power accuracy. Australian and New Zealand Journal of Ophthalmology 16(2): 111-117

Olson, R.J.; Kaufman, H.E. 1979: IOL quality: should we expect more?. Journal - American Intra-Ocular Implant Society 5(1): 2-3

McIntyre, D.J. 1979: IOL terminology. Journal-AmericanIntra-OcularImplantSociety 5(1): 41

Tennant, J.L. 1978: IOLAB intraocular lenses: adverse effects. Journal-American Intra-Ocular Implant Society 4(4): 210

Magruder, G.B. 1978: IOLAB intraocular lenses: adverse reactions. Journal - American Intra-Ocular Implant Society 4(4): 209-210

DeHaven, C.R. 1978: IOLAB "Choyce" anterior chamber lens. Journal-American Intra-Ocular Implant Society 4(2): 67

McEwan, J. 1986: IOLSTAT--a program for comprehensive intraocular lens equation comparison with statistical analysis. Journal of Cataract and Refractive Surgery 12(5): 543-549

Kulvin, S.M. 1979: IOLs and anticoagulant therapy. Journal-American Intra-Ocular Implant Society 5(1): 37

Maida, J.W. 1979: IOLs and anticoagulation therapy. Journal-American Intra-Ocular Implant Society 5(1): 36

Choyce, D.P. 1979: IOLs in children. Journal - American Intra-Ocular Implant Society 5(2): 146-147

Beem, J.W. 1978: IOLs: quality control during production. Journal-American Intra-Ocular Implant Society 4(3): 121

Bauknecht, V.L. 1985: IOM Committee releases NIH study report. American Nurse 17(1): 2

Sun, M. 1988: IOM and Soviet Academy sign first exchange pact. Science 239(4839): 458

Culliton, B.J. 1988: IOM names committee to study NIH. Science 240(4858): 1401

Mohan, R.; Brewster, L.J.; Barest, G.D.; Chui, C.S. 1989: Computer graphics tools for radiation treatment planning. Computer Methods and Programs in Biomedicine 28(3): 157-170

Liddell, F.H. 1976: IOM study analyzes medicare/medicaid reimbursement of teaching physicians. Hospitals 50(13): 30

Mazzaschi, A. 1989: IOM study finds NIH's intramural program 'invaluable'. Urges some administrative changes. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 3(2): 115-116

Cruzan, J. 1991: Activity--not higher hematocrits--can be key to feeling better on dialysis. Nephrology News and Issues 5(5): 13

Stone, R. 1992: IOM weighs in on microbial threat. Science 258(5082): 540

Norman, C. 1985: IOM's future under review. Science 227(4691): 1186

Bigar, F. 1985: IOMSG microscope report 1984. Developments in Ophthalmology 11: 5-11

Draeger, J.; Schneider, C. 1975: IOP and direction of gaze in endocrine exophthalmos. Modern Problems in Ophthalmology 14: 439-445

Dewald, B.; Moser, B.; Barella, L.; Schumacher, C.; Baggiolini, M.; Clark-Lewis, I. 1992: IP-10, a gamma-interferon-inducible protein related to interleukin-8, lacks neutrophil activating properties. Immunology Letters 32(1): 81-84

Auwerx, J.; Sassone-Corsi, P. 1991: IP-1: a dominant inhibitor of Fos/Jun whose activity is modulated by phosphorylation. Cell 64(5): 983-993

Allen, M.J.; Carpenter, J.R. 1992: IP3 and GTP gamma S cause contraction of permeabilised guinea pig ileum longitudinal smooth muscle via distinct mechanisms. Advances in Experimental Medicine and Biology 311: 351-353

Aducci, P.; Marra, M. 1990: IP3 levels and their modulation FY fusicoccin measured by a novel [3H] IP3 binding assay. Biochemical and Biophysical Research Communications 168(3): 1041-1046

Khan, A.A.; Steiner, J.P.; Klein, M.G.; Schneider, M.F.; Snyder, S.H. 1992: IP3 receptor: localization to plasma membrane of T cells and cocapping with the T cell receptor. Science 257(5071): 815-818

Miyamoto, T.; Restrepo, D.; Cragoe, E.J.; Teeter, J.H. 1992: IP3- and cAMP-induced responses in isolated olfactory receptor neurons from the channel catfish. Journal of Membrane Biology 127(3): 173-183

Perretti, F.; Nediani, C.; Manzini, S. 1990: IP66 (1[2-ethoxy-2-(3'-pyridyl)ethyl]-4-(2'-methoxy-phenyl)piperazine) enhances beta-adrenoceptor-induced vasodilatation in rat mesenteric vascular bed. Archives Internationales de Pharmacodynamie et de Therapie 306: 87-99

Ashley, J.T. 1992: IPA payment policies for preventive services. American Journal of Preventive Medicine 8(2): 130

Anonymous 1976: IPA plan in Rochester, N.Y. terminates; subscribers offered three coverage options. Employee Benefit Plan Review 31(1): 8-9

Sheppard, E.E. 1986: IPA's--an alternative to discount dentistry. Journal - Oklahoma Dental Association 77(2): 24-25

Zellmer, W.A. 1988: IPA: vital resource for pharmacy practice. American Journal of Hospital Pharmacy 45(11): 2327

Alvarez, D.A. 1985: IPAs...still a controversy. Delaware Medical Journal 57(10): 619-620

Koda, A.; Yanagihara, Y.; Matsuura, N. 1991: IPD-1151T: a prototype drug for IgE antibody synthesis modulation. Agents and Actions. Supplements 34: 369-378

Altland, K. 1990: IPGMAKER: a program for IBM-compatible personal computers to create and test recipes for immobilized pH gradients. Electrophoresis 11(2): 140-147

Sidorenko, S.P.; Vetrova, E.P.; Berdova, A.G.; Shlapatskaia, L.N.; Evsev'eva, A.I. 1988: IPO-10 monoclonal antibodies to the human B-lymphocyte differentiation antigen. Eksperimental'naia Onkologiia 10(3): 42-44

Starke, I.D.; Webber, B.A.; Branthwaite, M.A. 1979: IPPB and hypercapnia in respiratory failure: the effect of different concentrations of inspired oxygen on arterial blood gas tensions. Anaesthesia 34(3): 283-287

Motley, H.L. 1976: IPPB in severe pulmonary emphysema: successful results. Respiratory Therapy 6(4): 47; 50-55

Noehren, T.H. 1975: IPPB therapy - where do we go from here?. Chest 67(4): 471-472

Kauffmann, F.; Drouet, D.; Brille, D.; Hatzfeld, C.; Liot, F.; Kompalitch, M. 1979: IPPB therapy at home in chronic respiratory insufficiency in France. II. Indications. Technics and surveillance. Revue Francaise des Maladies Respiratoires 7(4): 370-376

Wiggs, S.M. 1978: IPPB with bronchodilators and Entonox. PhysioTherapy 64(2): 43-44

Katsuya, H.; Morioka, T.; Isa, T. 1976: IPPB, tracheo-bronchial lavage and general anesthesia for the intractable status asthmaticus. Kokyu to Junkan. Respiration and Circulation 24(3): 237-241

Gaynon, P.S.; Steinherz, P.G.; Bleyer, W.A.; Ablin, A.R.; Albo, V.C.; Finklestein, J.Z.; Grossman, N.J.; Littman, P.S.; Novak, L.T.; Pyesmany, A.F. 1988: Intensive therapy for children with acute lymphoblastic leukaemia and unfavourable presenting features. Early conclusions of study CCG-106 by the Childrens Cancer Study Group. Lancet 2(8617): 921-924

Anonymous 1985: IPPNW's role. Lancet 1(8441): 1334

Wareham, S. 1992: IPPNW, 1991: disarmament, development and the environment. Medical Journal of Australia 156(7): 443-444

Anonymous 1991: IPPNW--resting on its Nobel laurels?. Lancet 338(8759): 90

Burk, N.; Benumof, J.L.; Ozaki, G.T.; Miller, L.; Howell, H.B. 1991: IPPV plus low-flow intermittent oxygen insufflation (end-exhalation to beginning inhalation) does not improve CO2 elimination. Journal of Cardiothoracic and Vascular Anesthesia 5(1): 46-50

Heinenberg, B.J. 1991: IPS-Empress with new ceramic technology. Die Quintessenz der Zahntechnik 17(4): 475-479

Unterbrink, G. 1991: IPS-Empress. new full ceramic system. Zwr 100(10): 786-788; 791

Beham, G. 1991: IPS-Empress: a new ceramic technology. Zwr 100(6): 404-408

Schulze-Kremer, S.; King, R.D. 1992: IPSA-Inductive Protein Structure Analysis. Protein Engineering 5(5): 377-390

Cheah, L.H.; Parkin, A.; Gilson, P.; Elliot, S.; Hall, A.J. 1989: Limb volume measurements in peripheral arterial disease. Clinical Physics and Physiological Measurement: An Official Journal of the Hospital Physicists' Association Deutsche Gesellschaft für Medizinische Physik and the European Federation of Organisations for Medical Physics 10(1): 75-79

Rodriguez, J.F.; Smith, G.L. 1990: IPTG-dependent vaccinia virus: identification of a virus protein enabling virion envelopment by Golgi membrane and egress. Nucleic Acids Research 18(18): 5347-5351

Anonymous 1986: IQ (2-amino-3-methylimidazo[4,5-f]quinoline). IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans 40: 261-273

Moffitt, T.E.; Silva, P.A. 1988: IQ and delinquency: a direct test of the differential detection hypothesis. Journal of Abnormal Psychology 97(3): 330-333

Havender, W.R. 1978: IQ and environmental variables. Nature 272(5655): 666

Gibbons, A.; Kessler, D.A. 1991: Can David Kessler revive the FDA?. Science 252(5003): 200-203

Bryan, T. 1989: IQ and learning disabilities: a perspective from research on social factors. Journal of Learning Disabilities 22(8): 480-481

Cornwall, A. 1991: IQ and reading progress. Journal of the American Academy of Child and Adolescent Psychiatry 30(4): 696-698